| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulator activity | 1.71e-06 | 18 | 237 | 5 | GO:0035014 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase activator activity | 2.33e-06 | 9 | 237 | 4 | GO:0141038 | |
| GeneOntologyMolecularFunction | kinase binding | PDE3B CEBPB IRS1 LYST ITGB3 TRIM64C GFAP ADRA2A PIK3R1 KCNQ3 PPP1R9B LRRC7 MAP4K2 DNM2 AGAP2 KIF13B VIM MICAL1 CACNB4 ANK2 XBP1 PITPNM1 LATS1 ARRB2 MTOR MICAL2 LRBA | 3.51e-05 | 969 | 237 | 27 | GO:0019900 |
| GeneOntologyMolecularFunction | actin binding | SPATA31A7 TMOD2 NEB TLN2 PPP1R9B MICAL1 SHROOM3 SPATA31A3 MYH7B TRIOBP SPATA31A5 SHANK3 SPATA31A1 MICAL2 CTNNA3 MACF1 LSP1 | 6.28e-05 | 479 | 237 | 17 | GO:0003779 |
| GeneOntologyMolecularFunction | protein kinase binding | PDE3B IRS1 LYST ITGB3 TRIM64C ADRA2A PIK3R1 KCNQ3 LRRC7 MAP4K2 DNM2 AGAP2 KIF13B VIM MICAL1 CACNB4 ANK2 XBP1 PITPNM1 LATS1 ARRB2 MTOR MICAL2 LRBA | 1.20e-04 | 873 | 237 | 24 | GO:0019901 |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 1.50e-04 | 43 | 237 | 5 | GO:0043548 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 1.58e-04 | 97 | 237 | 7 | GO:0008081 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 2.54e-04 | 11 | 237 | 3 | GO:0016303 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDK20 DCAKD SMG1 STK36 RPS6KA1 RPS6KA2 OBSCN NEK2 PIK3C2B PIK3R1 PPP1R9B FGFR3 MAP4K2 WNK3 DDR1 FLT3 LATS1 MTOR PRKDC ATM | 3.23e-04 | 709 | 237 | 20 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | CDK20 DCAKD SMG1 STK36 RPS6KA1 RPS6KA2 OBSCN NEK2 PIK3C2B PIK3R1 PPP1R9B FGFR3 MAP4K2 WNK3 DDR1 FLT3 LATS1 MTOR CARD11 PRKDC ATM | 3.23e-04 | 764 | 237 | 21 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDK20 DCAKD SMG1 STK36 RPS6KA1 RPS6KA2 OBSCN NEK2 PIK3C2B PIK3R1 PPP1R9B FGFR3 MAP4K2 WNK3 PCYT1B DDR1 FLT3 POLD1 LATS1 MTOR FLAD1 CARD11 PRKDC ATM | 3.47e-04 | 938 | 237 | 24 | GO:0016772 |
| GeneOntologyMolecularFunction | DNA-dependent protein kinase activity | 4.18e-04 | 3 | 237 | 2 | GO:0004677 | |
| GeneOntologyMolecularFunction | alpha-1B adrenergic receptor binding | 4.18e-04 | 3 | 237 | 2 | GO:0031692 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 4.18e-04 | 3 | 237 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | CDK20 SMG1 STK36 RPS6KA1 RPS6KA2 OBSCN NEK2 MAP4K2 WNK3 LATS1 MTOR PRKDC ATM | 4.23e-04 | 363 | 237 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | OBSCN ANKRD27 SBF1 FGD1 HERC2 HERC1 MCF2L RASGRF2 ARHGEF18 MADD | 4.57e-04 | 231 | 237 | 10 | GO:0005085 |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulatory subunit binding | 5.46e-04 | 14 | 237 | 3 | GO:0036312 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | SPATA31A7 OBSCN TMOD2 NEB DES TLN2 PPP1R9B CAMSAP2 DNM2 KIF13B MICAL1 SHROOM3 SPATA31A3 ANK2 VEZT MYH7B TRIOBP SPATA31A5 SHANK3 SPATA31A1 MICAL2 PDCD5 CTNNA3 MACF1 LSP1 KIF13A | 6.42e-04 | 1099 | 237 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | protein kinase activity | CDK20 SMG1 STK36 RPS6KA1 RPS6KA2 OBSCN NEK2 PPP1R9B FGFR3 MAP4K2 WNK3 DDR1 FLT3 LATS1 MTOR PRKDC ATM | 8.63e-04 | 600 | 237 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.18e-03 | 18 | 237 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 1.37e-03 | 5 | 237 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.46e-03 | 70 | 237 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.61e-03 | 227 | 237 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 1.62e-03 | 20 | 237 | 3 | GO:0061608 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport to the plasma membrane | SNX3 ATP6AP1 ANKRD27 EHD4 EHD3 EHD1 LRRC7 CCDC93 DNM2 MACF1 KIF13A GGA1 | 7.51e-07 | 172 | 237 | 12 | GO:0098876 |
| GeneOntologyBiologicalProcess | endosomal transport | SNX3 ATP6AP1 WDR81 LYST ANKRD27 EHD4 EHD3 EHD1 MTMR2 LRRC7 HEATR5B VCP CCDC93 AGAP2 LRBA GGA1 | 9.97e-07 | 320 | 237 | 16 | GO:0016197 |
| GeneOntologyBiologicalProcess | protein localization to organelle | CDK20 OBSCN TMCO6 IRS1 JARID2 PIK3R1 BTF3 EHD1 KCNQ3 PPP1R9B LRRC7 PLRG1 VCP KPNA3 KPNA4 CACNB4 ANK2 COG7 XBP1 HUWE1 AP3B1 CCT6A LATS1 ZNF827 MTOR RRAGA SCG3 PDCD5 CEP250 MACF1 GGA1 | 3.11e-06 | 1091 | 237 | 31 | GO:0033365 |
| GeneOntologyBiologicalProcess | regulation of opioid receptor signaling pathway | 5.94e-06 | 4 | 237 | 3 | GO:2000474 | |
| GeneOntologyBiologicalProcess | actin filament-based process | PDE4D OBSCN TMOD2 NEB ITGB3 ADRA2A PIK3R1 FGD1 TLN2 PPP1R9B DNM2 AGAP2 MICAL1 SHROOM3 ANK2 MYH7B TRIOBP ARHGEF18 ARHGAP35 SHANK3 LATS1 RNH1 MTOR MICAL2 PPM1F CTNNA3 GRHL3 | 6.80e-06 | 912 | 237 | 27 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | PDE4D TMOD2 NEB ITGB3 PIK3R1 ANK2 MYH7B TRIOBP ARHGEF18 ARHGAP35 SHANK3 LATS1 RNH1 MTOR PPM1F CTNNA3 GRHL3 | 1.36e-05 | 438 | 237 | 17 | GO:0032970 |
| GeneOntologyBiologicalProcess | endocytic recycling | 1.39e-05 | 95 | 237 | 8 | GO:0032456 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | PDE3B OBSCN IRS1 PIK3C2B PIK3R1 FGFR3 AIM2 AGAP2 DDR1 COL6A3 FLT3 XBP1 ARRB2 MTOR PPP1R16B | 3.86e-05 | 382 | 237 | 15 | GO:0043491 |
| GeneOntologyBiologicalProcess | intracellular transport | SMG1 ABCA2 SNX3 ATP6AP1 WDR81 TMCO6 LYST GFAP ANKRD27 EHD4 EHD3 PIK3R1 TGFBRAP1 EHD1 MTMR2 KCNQ3 LRRC7 HERC2 HEATR5B VCP CCDC93 AGAP2 KPNA3 KPNA4 KIF13B COG7 TSNARE1 XBP1 AP3B1 MADD PDCD5 AP3B2 LRBA KIF13A GGA1 | 4.58e-05 | 1496 | 237 | 35 | GO:0046907 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | OBSCN TMOD2 NEB ITGB3 ADRA2A PIK3R1 FGD1 TLN2 PPP1R9B DNM2 AGAP2 MICAL1 SHROOM3 TRIOBP ARHGEF18 ARHGAP35 SHANK3 LATS1 RNH1 MTOR MICAL2 PPM1F GRHL3 | 5.63e-05 | 803 | 237 | 23 | GO:0030036 |
| GeneOntologyBiologicalProcess | organelle assembly | STK36 OBSCN TMOD2 NEB LRRC43 EHD4 EHD3 ACTL7A CSDE1 NEK2 EHD1 DNAH8 WNK3 DNM2 NSUN4 LIMD1 HAUS5 ARHGAP35 AP3B1 SHANK3 DNAH1 CELSR2 MTOR CEP250 DNAH17 PRKDC ATM LRBA | 1.23e-04 | 1138 | 237 | 28 | GO:0070925 |
| GeneOntologyBiologicalProcess | protein localization to M-band | 1.31e-04 | 2 | 237 | 2 | GO:0036309 | |
| GeneOntologyBiologicalProcess | positive regulation of opioid receptor signaling pathway | 1.31e-04 | 2 | 237 | 2 | GO:2000476 | |
| GeneOntologyBiologicalProcess | sulfur oxidation | 1.31e-04 | 2 | 237 | 2 | GO:0019417 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | SNX3 ATP6AP1 TMCO6 GFAP PIK3R1 TGFBRAP1 EHD1 KCNQ3 LRRC7 HERC2 VCP KPNA3 KPNA4 COG7 TSNARE1 XBP1 AP3B1 PDCD5 AP3B2 KIF13A GGA1 | 1.36e-04 | 740 | 237 | 21 | GO:0006886 |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | ABCA2 SNX3 RPS6KA2 TMOD2 ITGB3 GFAP ANKRD27 PIK3R1 MTMR2 MINAR1 FGFR3 CAMSAP2 DNM2 PLXNA3 VIM TRIOBP ARHGEF18 HUWE1 SHANK3 ARRB2 ZNF827 MTOR ATM | 1.67e-04 | 864 | 237 | 23 | GO:0051129 |
| Domain | FATC | 1.21e-07 | 5 | 235 | 4 | PF02260 | |
| Domain | FATC_dom | 3.59e-07 | 6 | 235 | 4 | IPR003152 | |
| Domain | FATC | 3.59e-07 | 6 | 235 | 4 | SM01343 | |
| Domain | FAT | 3.59e-07 | 6 | 235 | 4 | PS51189 | |
| Domain | FATC | 3.59e-07 | 6 | 235 | 4 | PS51190 | |
| Domain | PIK_FAT | 3.59e-07 | 6 | 235 | 4 | IPR014009 | |
| Domain | PI3/4_kinase_CS | 8.19e-07 | 15 | 235 | 5 | IPR018936 | |
| Domain | PI3Kc | 1.18e-06 | 16 | 235 | 5 | SM00146 | |
| Domain | - | 1.18e-06 | 16 | 235 | 5 | 1.10.1070.11 | |
| Domain | ARM-type_fold | SMG1 STK36 RSPH14 TMCO6 LYST NCAPG PIK3C2B HEATR5B KPNA3 KPNA4 HUWE1 AP3B1 MTOR AP3B2 PRKDC ATM LRBA | 1.49e-06 | 339 | 235 | 17 | IPR016024 |
| Domain | PI3/4_kinase_cat_dom | 2.27e-06 | 18 | 235 | 5 | IPR000403 | |
| Domain | PI3_PI4_kinase | 2.27e-06 | 18 | 235 | 5 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 2.27e-06 | 18 | 235 | 5 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.27e-06 | 18 | 235 | 5 | PS00916 | |
| Domain | PI3_4_KINASE_3 | 2.27e-06 | 18 | 235 | 5 | PS50290 | |
| Domain | Kinase-like_dom | CDK20 SMG1 STK36 RPS6KA1 RPS6KA2 OBSCN WDR81 NEK2 PIK3C2B FGFR3 MAP4K2 WNK3 DNM2 DDR1 FLT3 ARHGAP35 LATS1 MTOR MACF1 PRKDC ATM | 5.35e-06 | 542 | 235 | 21 | IPR011009 |
| Domain | ARM-like | SMG1 STK36 RSPH14 TMCO6 NCAPG HEATR5B KPNA3 KPNA4 HUWE1 AP3B1 MTOR AP3B2 PRKDC LRBA | 8.76e-06 | 270 | 235 | 14 | IPR011989 |
| Domain | EHD_N | 1.93e-05 | 5 | 235 | 3 | IPR031692 | |
| Domain | EHD_N | 1.93e-05 | 5 | 235 | 3 | PF16880 | |
| Domain | G_DYNAMIN_dom | 2.21e-05 | 14 | 235 | 4 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 2.21e-05 | 14 | 235 | 4 | PS51718 | |
| Domain | - | STK36 RSPH14 TMCO6 NCAPG HEATR5B KPNA3 KPNA4 AP3B1 MTOR AP3B2 PRKDC LRBA | 2.57e-05 | 222 | 235 | 12 | 1.25.10.10 |
| Domain | P-loop_NTPase | DCAKD ABCA2 ZRANB3 EHD4 EHD3 EHD1 GAL3ST3 ASCC3 GTPBP3 DNAH8 VCP DNM2 AGAP2 KIF13B CACNB4 MYH7B CHD7 ARHGAP35 DNAH1 ARHGAP5 RRAGA IRGC CARD11 KIF13A FIGNL1 SMC1B | 2.61e-05 | 848 | 235 | 26 | IPR027417 |
| Domain | PH_dom-like | NUMBL OBSCN IRS1 LYST SBF1 MTMR2 FGD1 TLN2 MCF2L DNM2 AGAP2 RASGRF2 TRIOBP ARHGEF18 PLCD3 LRBA PLCH1 | 2.99e-05 | 426 | 235 | 17 | IPR011993 |
| Domain | Dynamin_GTPase | 2.99e-05 | 15 | 235 | 4 | IPR001401 | |
| Domain | Dynamin_SF | 2.99e-05 | 15 | 235 | 4 | IPR022812 | |
| Domain | Dynamin_N | 2.99e-05 | 15 | 235 | 4 | PF00350 | |
| Domain | PIK-rel_kinase_FAT | 3.82e-05 | 6 | 235 | 3 | IPR003151 | |
| Domain | FAT | 3.82e-05 | 6 | 235 | 3 | PF02259 | |
| Domain | Leu-rich_rpt | LRRC24 NRROS LRRC43 ANP32E LRRC7 KERA SKP2 OMG LRR1 RNH1 LRRC53 LRRN4 LRIT1 | 4.14e-05 | 271 | 235 | 13 | IPR001611 |
| Domain | - | LRRC24 TMOD2 NRROS LRRC43 ANP32E LRRC7 KERA SKP2 OMG LRR1 RNH1 LRRC53 LRRN4 LRIT1 | 5.93e-05 | 321 | 235 | 14 | 3.80.10.10 |
| Domain | Filament_head | 6.63e-05 | 7 | 235 | 3 | PF04732 | |
| Domain | Intermed_filament_DNA-bd | 6.63e-05 | 7 | 235 | 3 | IPR006821 | |
| Domain | - | DCAKD ABCA2 ZRANB3 EHD4 EHD3 EHD1 GAL3ST3 ASCC3 GTPBP3 DNAH8 VCP DNM2 AGAP2 CACNB4 CHD7 ARHGAP35 DNAH1 ARHGAP5 RRAGA IRGC CARD11 FIGNL1 SMC1B | 7.19e-05 | 746 | 235 | 23 | 3.40.50.300 |
| Domain | L_dom-like | LRRC24 TMOD2 NRROS LRRC43 ANP32E LRRC7 KERA SKP2 OMG LRR1 RNH1 LRRC53 LRRN4 LRIT1 | 7.47e-05 | 328 | 235 | 14 | IPR032675 |
| Domain | LRR_1 | LRRC24 NRROS ANP32E LRRC7 KERA SKP2 OMG LRR1 RNH1 LRRN4 LRIT1 | 1.08e-04 | 219 | 235 | 11 | PF00560 |
| Domain | - | NUMBL OBSCN IRS1 SBF1 MTMR2 FGD1 TLN2 MCF2L DNM2 AGAP2 RASGRF2 TRIOBP ARHGEF18 PLCD3 PLCH1 | 1.36e-04 | 391 | 235 | 15 | 2.30.29.30 |
| Domain | BEACH | 1.56e-04 | 9 | 235 | 3 | PS50197 | |
| Domain | Beach | 1.56e-04 | 9 | 235 | 3 | SM01026 | |
| Domain | Importin-a_IBB | 1.56e-04 | 9 | 235 | 3 | IPR002652 | |
| Domain | BEACH_dom | 1.56e-04 | 9 | 235 | 3 | IPR000409 | |
| Domain | Beach | 1.56e-04 | 9 | 235 | 3 | PF02138 | |
| Domain | - | 1.56e-04 | 9 | 235 | 3 | 1.10.1540.10 | |
| Domain | AP3_beta | 1.58e-04 | 2 | 235 | 2 | IPR026740 | |
| Domain | AP3B_C | 1.58e-04 | 2 | 235 | 2 | IPR029390 | |
| Domain | RhoGAP-FF1 | 1.58e-04 | 2 | 235 | 2 | PF16512 | |
| Domain | AP3B1_C | 1.58e-04 | 2 | 235 | 2 | PF14796 | |
| Domain | AP3B1_C | 1.58e-04 | 2 | 235 | 2 | SM01355 | |
| Domain | ATM/Tel1 | 1.58e-04 | 2 | 235 | 2 | IPR015519 | |
| Domain | RhoGAP-FF1 | 1.58e-04 | 2 | 235 | 2 | IPR032835 | |
| Domain | EHD1/EHD3 | 1.58e-04 | 2 | 235 | 2 | IPR029951 | |
| Domain | PH | OBSCN IRS1 SBF1 FGD1 MCF2L DNM2 AGAP2 RASGRF2 TRIOBP ARHGEF18 PLCD3 PLCH1 | 2.20e-04 | 278 | 235 | 12 | SM00233 |
| Domain | EF-hand_4 | 2.21e-04 | 10 | 235 | 3 | PF12763 | |
| Domain | PH_DOMAIN | OBSCN IRS1 SBF1 FGD1 MCF2L DNM2 AGAP2 RASGRF2 TRIOBP ARHGEF18 PLCD3 PLCH1 | 2.27e-04 | 279 | 235 | 12 | PS50003 |
| Domain | PH_domain | OBSCN IRS1 SBF1 FGD1 MCF2L DNM2 AGAP2 RASGRF2 TRIOBP ARHGEF18 PLCD3 PLCH1 | 2.35e-04 | 280 | 235 | 12 | IPR001849 |
| Domain | LRR | 2.39e-04 | 201 | 235 | 10 | PS51450 | |
| Domain | EH | 3.01e-04 | 11 | 235 | 3 | PS50031 | |
| Domain | EH | 3.01e-04 | 11 | 235 | 3 | SM00027 | |
| Domain | EH_dom | 3.01e-04 | 11 | 235 | 3 | IPR000261 | |
| Domain | LRR_8 | 3.23e-04 | 171 | 235 | 9 | PF13855 | |
| Domain | DUF4599 | 3.98e-04 | 12 | 235 | 3 | PF15371 | |
| Domain | DUF4599 | 3.98e-04 | 12 | 235 | 3 | IPR027970 | |
| Domain | Leu-rich_rpt_typical-subtyp | 4.16e-04 | 177 | 235 | 9 | IPR003591 | |
| Domain | LRR_TYP | 4.16e-04 | 177 | 235 | 9 | SM00369 | |
| Domain | G_IRG_dom | 4.69e-04 | 3 | 235 | 2 | IPR030385 | |
| Domain | G_IRG | 4.69e-04 | 3 | 235 | 2 | PS51716 | |
| Domain | PH | OBSCN IRS1 SBF1 FGD1 MCF2L DNM2 AGAP2 RASGRF2 TRIOBP ARHGEF18 | 6.68e-04 | 229 | 235 | 10 | PF00169 |
| Domain | FERM_f0 | 9.30e-04 | 4 | 235 | 2 | PF16511 | |
| Domain | FERM_f0 | 9.30e-04 | 4 | 235 | 2 | IPR032425 | |
| Domain | Kinesin-like_KIF1-typ | 9.30e-04 | 4 | 235 | 2 | IPR022140 | |
| Domain | KIF1B | 9.30e-04 | 4 | 235 | 2 | PF12423 | |
| Domain | DH_1 | 1.17e-03 | 63 | 235 | 5 | PS00741 | |
| Domain | AP_beta | 1.54e-03 | 5 | 235 | 2 | IPR026739 | |
| Domain | zf-C5HC2 | 1.54e-03 | 5 | 235 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 1.54e-03 | 5 | 235 | 2 | IPR004198 | |
| Domain | RhoGEF | 1.65e-03 | 68 | 235 | 5 | SM00325 | |
| Domain | EF_Hand_1_Ca_BS | 1.71e-03 | 175 | 235 | 8 | IPR018247 | |
| Domain | RhoGEF | 1.88e-03 | 70 | 235 | 5 | PF00621 | |
| Domain | HEAT_REPEAT | 1.88e-03 | 70 | 235 | 5 | PS50077 | |
| Domain | DH_2 | 1.88e-03 | 70 | 235 | 5 | PS50010 | |
| Domain | - | 2.00e-03 | 71 | 235 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 2.00e-03 | 71 | 235 | 5 | IPR000219 | |
| Domain | Kinesin_assoc | 2.29e-03 | 6 | 235 | 2 | PF16183 | |
| Domain | - | 2.29e-03 | 6 | 235 | 2 | 2.60.40.1230 | |
| Domain | FF_domain | 2.29e-03 | 6 | 235 | 2 | IPR002713 | |
| Domain | PH_BEACH | 2.29e-03 | 6 | 235 | 2 | PF14844 | |
| Domain | FAD_binding_3 | 2.29e-03 | 6 | 235 | 2 | PF01494 | |
| Domain | FF | 2.29e-03 | 6 | 235 | 2 | SM00441 | |
| Domain | Kinesin_assoc | 2.29e-03 | 6 | 235 | 2 | IPR032405 | |
| Domain | FAD-bd | 2.29e-03 | 6 | 235 | 2 | IPR002938 | |
| Domain | FF | 2.29e-03 | 6 | 235 | 2 | PS51676 | |
| Domain | Kinesin-like | 2.29e-03 | 6 | 235 | 2 | IPR022164 | |
| Domain | FF | 2.29e-03 | 6 | 235 | 2 | PF01846 | |
| Domain | Clathrin_g-adaptin_app | 2.29e-03 | 6 | 235 | 2 | IPR008153 | |
| Domain | Ribosomal_S6_kinase_II | 2.29e-03 | 6 | 235 | 2 | IPR016239 | |
| Domain | DUF3694 | 2.29e-03 | 6 | 235 | 2 | PF12473 | |
| Domain | Armadillo | 2.85e-03 | 47 | 235 | 4 | IPR000225 | |
| Domain | Arm_3 | 3.18e-03 | 7 | 235 | 2 | PF16186 | |
| Domain | TFS2M | 3.18e-03 | 7 | 235 | 2 | SM00510 | |
| Domain | Importing_su_alpha | 3.18e-03 | 7 | 235 | 2 | IPR024931 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | STK36 ABCA2 CEBPB LRRC24 RPS6KA2 OBSCN TMCO6 IRS1 LYST ADCY9 SBF1 PIK3C2B PDZD8 TLN2 HERC2 HERC1 MCF2L PLXNA3 SHROOM3 TSNARE1 HUWE1 MED13L ARHGAP35 ZBTB42 MADD PLCD3 CELSR2 ZNF827 MTOR BTBD7 NINL PRKDC LRBA GGA1 | 3.35e-13 | 1105 | 240 | 34 | 35748872 |
| Pubmed | ENPP6 DLGAP1 PDE4D ATP6AP1 NUMBL TMOD2 PLD3 GFAP EHD3 CSDE1 SBF1 EHD1 MTMR2 KCNQ3 TLN2 PPP1R9B LRRC7 CAMSAP2 VCP DNM2 AGAP2 KPNA3 VIM MICAL1 CACNB4 ANK2 ARHGAP35 AP3B1 OMG SHANK3 MADD PITPNM1 ARHGAP5 CCT6A MICAL2 AP3B2 MACF1 PLCH1 | 1.07e-12 | 1431 | 240 | 38 | 37142655 | |
| Pubmed | TET2 DLGAP1 ABCA2 ADARB1 GFAP XAB2 CSDE1 NAA25 PIK3R1 MTMR2 PDZD8 TLN2 HERC2 VCP DNM2 AGAP2 KPNA3 KPNA4 VIM JCAD ANK2 TRIOBP HUWE1 MED13L MADD THAP4 ARHGAP5 CIAO3 MICAL2 SCG3 PPP1R16B MACF1 PRKDC ATM LRBA | 4.60e-12 | 1285 | 240 | 35 | 35914814 | |
| Pubmed | DLGAP1 LRRC24 NUMBL RPS6KA2 WDR81 EHD3 CNTNAP5 SBF1 ZBTB21 TLN2 PPP1R9B LRRC7 HERC2 CAMSAP2 WNK3 DNM2 AGAP2 KIF13B VIM CACNB4 SHROOM3 ANK2 TRIOBP ARHGEF18 CHD7 HUWE1 SHANK3 CELSR2 MTOR MACF1 | 6.88e-12 | 963 | 240 | 30 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 PDE3B SNX3 NUMBL RPS6KA2 IRS1 LYST ANKRD27 SBF1 PIK3C2B ZBTB21 CAMSAP2 WNK3 KIF13B VIM JCAD SHROOM3 LIMD1 MADD LATS1 MTOR PHF3 AASS MACF1 PLCH1 KIF13A | 3.72e-10 | 861 | 240 | 26 | 36931259 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | STK36 ESS2 KDM5D ITGB3 ZRANB3 PIK3R1 KPNA3 KPNA4 JCAD SHROOM3 ARHGEF18 CHD7 MAGEE1 LATS1 ARRB2 CCDC87 ATM | 9.96e-09 | 430 | 240 | 17 | 35044719 |
| Pubmed | EH domain proteins regulate cardiac membrane protein targeting. | 1.10e-08 | 5 | 240 | 4 | 20489164 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DLGAP1 PDE4D NUMBL TLN2 PPP1R9B LRRC7 AGAP2 ANK2 ARHGEF18 SHANK3 PITPNM1 MTOR PHF3 MACF1 | 1.18e-08 | 281 | 240 | 14 | 28706196 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DNAJB12 DCAKD PDE3B PDE4D NUMBL RPS6KA2 OBSCN ZNF385B PLD3 ADARB1 EHD3 CSDE1 TGFBRAP1 PPP1R9B LRRC7 MCF2L DDR1 SHROOM3 LIMD1 VEZT TSNARE1 TRIOBP ARHGEF18 HUWE1 ARHGAP35 DNAH1 THAP4 ARRB2 ZNF827 MICAL2 MACF1 LRBA | 1.37e-08 | 1489 | 240 | 32 | 28611215 |
| Pubmed | SMG1 CAGE1 COQ3 NEB LRRC43 LYST EHD4 DES NEK2 ZBTB21 PPP1R9B MCF2L CAMSAP2 DNAH8 AGAP2 KPNA4 PLXNA3 KIF13B VIM ANK2 MYH7B RYBP CCT6A LATS1 CIAO3 SCG3 DNAJC11 MACF1 PRKDC ATM PLCH1 | 2.34e-08 | 1442 | 240 | 31 | 35575683 | |
| Pubmed | DLGAP1 GFAP CSDE1 BTF3 KCNQ3 TLN2 PPP1R9B LRRC7 CAMSAP2 VCP AGAP2 VIM JCAD CACNB4 ANK2 VEZT TRIOBP HUWE1 ARHGAP35 SHANK3 MADD PITPNM1 CCT6A CELSR2 PDCD5 DNAJC11 MACF1 | 2.86e-08 | 1139 | 240 | 27 | 36417873 | |
| Pubmed | 3.28e-08 | 6 | 240 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 3.28e-08 | 6 | 240 | 4 | 25930072 | |
| Pubmed | DNAJB12 ATP6AP1 CEBPB NUMBL XAB2 CSDE1 JARID2 SBF1 BTF3 HERC2 ASCC3 HEATR5B CAMSAP2 ASF1A KPNA3 KPNA4 NSUN4 SHROOM3 POLD1 PHRF1 TRIOBP CHD7 AP3B1 PLCD3 CCT6A CGREF1 PHF3 EXD2 DNAJC11 MACF1 LAS1L | 5.43e-08 | 1497 | 240 | 31 | 31527615 | |
| Pubmed | DLGAP1 GFAP SBF1 PPP1R9B LRRC7 HERC2 CAMSAP2 AGAP2 VIM DDR1 SHANK3 CEP250 DNAJC11 AP3B2 CTNNA3 MACF1 | 6.30e-08 | 430 | 240 | 16 | 32581705 | |
| Pubmed | DCAKD ATP6AP1 NUMBL ADCY9 EHD4 NCAPG SBF1 PIK3R1 MTMR2 PDZD8 PPP1R9B HERC2 HERC1 KPNA3 KPNA4 VIM JCAD VEZT TRIOBP HUWE1 AP3B1 RBM20 MADD ARHGAP5 PPM1F | 8.72e-08 | 1049 | 240 | 25 | 27880917 | |
| Pubmed | 1.51e-07 | 8 | 240 | 4 | 20810650 | ||
| Pubmed | DNAJB12 DCAKD SMG1 PLD3 EHD4 CSDE1 NCAPG BTF3 EHD1 ANP32E ASCC3 VCP CCDC93 KPNA3 COG7 POLD1 SPTLC1 TRIOBP HUWE1 FHIP2A SKP2 CCT6A RNH1 MTOR AASS PRKDC ATM LAS1L FIGNL1 | 2.70e-07 | 1440 | 240 | 29 | 30833792 | |
| Pubmed | 3.25e-07 | 3 | 240 | 3 | 24794298 | ||
| Pubmed | 3.25e-07 | 3 | 240 | 3 | 2201025 | ||
| Pubmed | 3.25e-07 | 3 | 240 | 3 | 24019528 | ||
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 4.50e-07 | 10 | 240 | 4 | 18160036 | |
| Pubmed | DNAJB12 PDE3B ATP6AP1 NUMBL ZC3H13 PLD3 ADCY9 EHD4 NCAPG SBF1 PIK3R1 ANP32E PDZD8 HERC2 ASCC3 PLRG1 VCP SHROOM3 ANK2 VEZT POLD1 SPTLC1 TRIOBP AP3B1 DNAJC11 MACF1 ATM LAS1L PLCH1 | 5.21e-07 | 1487 | 240 | 29 | 33957083 | |
| Pubmed | SMG1 ADCY9 TLN2 MINAR1 TRIOBP CHD7 MED13L ARHGAP35 PHF3 PPP1R16B MACF1 | 5.38e-07 | 225 | 240 | 11 | 12168954 | |
| Pubmed | DNAJB12 CSDE1 NCAPG ASCC3 PLRG1 VCP DNM2 VIM COG7 POLD1 HUWE1 AP3B1 CCT6A RNH1 MTOR PRKDC LRBA LAS1L | 5.69e-07 | 638 | 240 | 18 | 33239621 | |
| Pubmed | DNAJB12 DCAKD PDE3B ABCA2 ANKRD27 XAB2 EHD4 NCAPG PIK3R1 EHD1 PDZD8 HERC2 ASCC3 HEATR5B AGAP2 POLD1 PHRF1 HUWE1 AP3B1 MTOR LSP1 PRKDC LRBA LAS1L GGA1 | 6.40e-07 | 1168 | 240 | 25 | 19946888 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 7.03e-07 | 11 | 240 | 4 | 20427287 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EHD4 NCAPG EHD1 TLN2 PLRG1 DNM2 VIM SHROOM3 POLD1 CHD7 HUWE1 AP3B1 CCT6A MACF1 PRKDC ATM LAS1L | 7.37e-07 | 582 | 240 | 17 | 20467437 |
| Pubmed | ZC3H13 XAB2 CSDE1 SBF1 HERC2 ASCC3 VCP DNM2 PHRF1 CHD7 HUWE1 RNH1 MTOR PHF3 MACF1 PRKDC ATM LAS1L | 7.94e-07 | 653 | 240 | 18 | 22586326 | |
| Pubmed | SMG1 ANKRD27 XAB2 PPP1R9B HERC2 ASCC3 HERC1 DNM2 LIMD1 HUWE1 PLCD3 ARHGAP5 ARRB2 CEP250 MACF1 KIF13A GGA1 | 9.09e-07 | 591 | 240 | 17 | 15231748 | |
| Pubmed | 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. | 1.07e-06 | 27 | 240 | 5 | 23027611 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PDE4D RPS6KA1 PLD3 EHD4 CSDE1 NCAPG BTF3 EHD1 MTMR2 ANP32E HERC1 ASF1A VCP KPNA3 KPNA4 VIM LIMD1 COG7 POLD1 HUWE1 AP3B1 CCT6A RNH1 MTOR MACF1 PRKDC LRBA KIF13A | 1.08e-06 | 1455 | 240 | 28 | 22863883 |
| Pubmed | C-terminal EH-domain-containing proteins: consensus for a role in endocytic trafficking, EH? | 1.29e-06 | 4 | 240 | 3 | 16155252 | |
| Pubmed | Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function. | 1.29e-06 | 4 | 240 | 3 | 29212907 | |
| Pubmed | 1.29e-06 | 4 | 240 | 3 | 20203102 | ||
| Pubmed | 1.29e-06 | 4 | 240 | 3 | 29954236 | ||
| Pubmed | 1.29e-06 | 4 | 240 | 3 | 10673336 | ||
| Pubmed | Novel Genetic Variants for Cartilage Thickness and Hip Osteoarthritis. | 1.29e-06 | 4 | 240 | 3 | 27701424 | |
| Pubmed | 1.29e-06 | 4 | 240 | 3 | 29196434 | ||
| Pubmed | 1.29e-06 | 4 | 240 | 3 | 17233914 | ||
| Pubmed | ITGB3 CSDE1 DHRS4 BTF3 MAP4K2 DNM2 VIM TRIOBP CCT6A RNH1 PDCD5 MACF1 PRKDC | 1.55e-06 | 360 | 240 | 13 | 33111431 | |
| Pubmed | DNAJB12 SNX3 ATP6AP1 ESS2 GATAD2A NUMBL PLD3 ANKRD27 EHD4 CSDE1 BTF3 EHD1 PDZD8 PLRG1 KPNA3 SPTLC1 LATS1 ARRB2 EXD2 PDCD5 LRBA GGA1 | 2.25e-06 | 1007 | 240 | 22 | 34597346 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GATAD2A ANKRD27 EHD4 CSDE1 NCAPG SBF1 EHD1 HERC2 ASCC3 PLRG1 VCP CCDC93 KPNA3 VIM POLD1 CHD7 HUWE1 PLCD3 CCT6A ARRB2 RNH1 MICAL2 PPM1F MACF1 PRKDC LAS1L | 2.76e-06 | 1353 | 240 | 26 | 29467282 |
| Pubmed | Elevated DNA double strand breaks and apoptosis in the CNS of scid mutant mice. | 3.21e-06 | 5 | 240 | 3 | 11319607 | |
| Pubmed | 3.21e-06 | 5 | 240 | 3 | 11684016 | ||
| Pubmed | 3.21e-06 | 5 | 240 | 3 | 19561084 | ||
| Pubmed | 3.21e-06 | 5 | 240 | 3 | 10635333 | ||
| Pubmed | SMG1 PDE3B RPS6KA1 ITGB3 ANKRD27 XAB2 CSDE1 SBF1 PLRG1 DNM2 AP3B1 FHIP2A RBM20 MADD PLCD3 PLCH1 FIGNL1 | 3.27e-06 | 650 | 240 | 17 | 38777146 | |
| Pubmed | DLGAP1 SNX3 CSDE1 PIK3C2B PIK3R1 DNM2 ANK2 POLD1 SHANK3 CELSR2 LRBA KIF13A | 3.55e-06 | 329 | 240 | 12 | 17474147 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SNX3 ESS2 GATAD2A ZC3H13 ANKRD27 XAB2 CSDE1 NCAPG BTF3 ANP32E ASCC3 PLRG1 DNM2 VIM POLD1 SPTLC1 CHD7 HUWE1 AP3B1 CCT6A RNH1 DNAJC11 PRKDC LRBA LAS1L | 5.43e-06 | 1318 | 240 | 25 | 30463901 |
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 6.26e-06 | 38 | 240 | 5 | 11756498 | |
| Pubmed | Doublecortin induces mitotic microtubule catastrophe and inhibits glioma cell invasion. | 6.39e-06 | 6 | 240 | 3 | 19094064 | |
| Pubmed | 6.39e-06 | 6 | 240 | 3 | 14966265 | ||
| Pubmed | 6.39e-06 | 6 | 240 | 3 | 10929709 | ||
| Pubmed | MICAL-L1 links EHD1 to tubular recycling endosomes and regulates receptor recycling. | 6.39e-06 | 6 | 240 | 3 | 19864458 | |
| Pubmed | 6.39e-06 | 6 | 240 | 3 | 16354680 | ||
| Pubmed | DNAJB12 IRS1 PIK3R1 BTF3 ASCC3 CAMSAP2 PLRG1 VCP DNM2 KPNA3 KPNA4 VIM POLD1 HUWE1 MED13L AP3B1 DNAH1 CCT6A LATS1 RNH1 MICAL2 PHF3 DNAJC11 PRKDC | 6.64e-06 | 1247 | 240 | 24 | 27684187 | |
| Pubmed | ESS2 GATAD2A TMOD2 TTC9C CSDE1 PIK3R1 BTF3 FGD1 PPP1R9B MCF2L PLRG1 DNM2 LIMD1 RASGRF2 SPTLC1 ARHGEF18 HUWE1 ARHGAP35 ARHGAP5 DNAJC11 | 6.66e-06 | 916 | 240 | 20 | 32203420 | |
| Pubmed | 6.77e-06 | 101 | 240 | 7 | 10997877 | ||
| Pubmed | CSDE1 NCAPG ASCC3 VIM LIMD1 HAUS5 HUWE1 ARHGAP35 AP3B1 CCT6A LATS1 PHF3 PDCD5 PRKDC LRBA | 7.46e-06 | 549 | 240 | 15 | 38280479 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | GATAD2A ZC3H13 EHD4 CSDE1 NCAPG BTF3 TLN2 LRRC7 CCDC93 DNM2 HAUS5 AP3B1 CCT6A PDCD5 CEP250 DNAJC11 AP3B2 MACF1 PRKDC | 7.82e-06 | 847 | 240 | 19 | 35235311 |
| Pubmed | BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A. | ESS2 NUMBL COQ3 TTC9C XAB2 HAUS5 SPTLC1 CHD7 IRGQ MTOR FLAD1 LRBA GGA1 | 8.04e-06 | 419 | 240 | 13 | 33001583 |
| Pubmed | DLGAP1 NEB GFAP CSDE1 DES PIK3R1 HERC2 KPNA4 MADD LATS1 ARRB2 CEP250 MACF1 PRKDC | 8.35e-06 | 486 | 240 | 14 | 20936779 | |
| Pubmed | ADCY9 SBF1 PIK3C2B PIK3R1 MTMR2 SPTLC1 TRIOBP ARHGAP5 ARRB2 CELSR2 MACF1 LRBA PLCH1 | 8.46e-06 | 421 | 240 | 13 | 36976175 | |
| Pubmed | 8.94e-06 | 147 | 240 | 8 | 16959763 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EHD4 NCAPG ANP32E ASCC3 DNAH8 KPNA4 KIF13B POLD1 SPTLC1 HUWE1 CPS1 AP3B1 CCT6A RNH1 MTOR PRKDC LRBA | 9.28e-06 | 704 | 240 | 17 | 29955894 |
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 9.99e-06 | 71 | 240 | 6 | 28319113 | |
| Pubmed | DNAJB12 NUMBL ADCY9 CSDE1 EHD1 PDZD8 LRRC7 ASCC3 VCP ANK2 AP3B1 CCT6A LATS1 MACF1 PRKDC LRBA PLCH1 | 9.99e-06 | 708 | 240 | 17 | 39231216 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | DNAJB12 DCAKD PDE3B PLD3 CSDE1 NAA25 NCAPG ASCC3 HEATR5B WNK3 VCP VEZT SPTLC1 HUWE1 AP3B1 MTOR PPM1F EXD2 DNAJC11 PRKDC | 1.00e-05 | 942 | 240 | 20 | 31073040 |
| Pubmed | 1.02e-05 | 197 | 240 | 9 | 36604605 | ||
| Pubmed | Desmoplakin and talin2 are novel mRNA targets of fragile X-related protein-1 in cardiac muscle. | 1.11e-05 | 7 | 240 | 3 | 21659647 | |
| Pubmed | Spinophilin blocks arrestin actions in vitro and in vivo at G protein-coupled receptors. | 1.11e-05 | 7 | 240 | 3 | 15218143 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | ESS2 NUMBL WDR81 SNX21 CSDE1 PIK3C2B HEATR5B CAMSAP2 PLRG1 VIM LIMD1 POLD1 HAUS5 AP3B1 FHIP2A MADD ARRB2 MTOR BTBD7 DNAJC11 LAS1L | 1.23e-05 | 1038 | 240 | 21 | 26673895 |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | ESS2 RPS6KA1 PLD3 NEK2 SBF1 C7orf25 MCF2L MAP4K2 VCP DNM2 PLXNA3 VIM MICAL1 DDR1 HAUS5 THAP4 MOXD1 MTOR FLAD1 PDCD5 DNAJC11 CARD11 | 1.27e-05 | 1124 | 240 | 22 | 21900206 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | DNAJB12 TMOD2 PLD3 ITIH2 DES NCAPG EHD1 VCP DNM2 VIM MYH7B HUWE1 RNH1 MTOR PRKDC LRBA | 1.28e-05 | 647 | 240 | 16 | 26618866 |
| Pubmed | 1.48e-05 | 76 | 240 | 6 | 27542412 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.57e-05 | 208 | 240 | 9 | 33230847 | |
| Pubmed | PLD3 PIK3R1 ANP32E GTPBP3 HAUS5 SPTLC1 CPS1 RNH1 AASS EXD2 FLAD1 PDCD5 DNAJC11 LAS1L | 1.59e-05 | 515 | 240 | 14 | 31617661 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DNAJB12 PDE3B ATP6AP1 ESS2 ADCY9 EHD4 PIK3R1 PDZD8 HERC2 HERC1 GTPBP3 VCP VIM VEZT SPTLC1 HUWE1 RBM20 CCT6A ARRB2 AASS EXD2 FLAD1 PDCD5 DNAJC11 LAS1L FIGNL1 | 1.61e-05 | 1496 | 240 | 26 | 32877691 |
| Pubmed | 1.66e-05 | 160 | 240 | 8 | 31678930 | ||
| Pubmed | 1.77e-05 | 8 | 240 | 3 | 19812254 | ||
| Pubmed | Lanthionine synthetase C-like protein 2 (LanCL2) is a novel regulator of Akt. | 1.77e-05 | 8 | 240 | 3 | 25273559 | |
| Pubmed | MyoD expression marks the onset of skeletal myogenesis in Myf-5 mutant mice. | 1.77e-05 | 8 | 240 | 3 | 7720554 | |
| Pubmed | LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. | 1.85e-05 | 79 | 240 | 6 | 26446488 | |
| Pubmed | 2.11e-05 | 24 | 240 | 4 | 32212159 | ||
| Pubmed | Substrate specificities and identification of putative substrates of ATM kinase family members. | 2.50e-05 | 25 | 240 | 4 | 10608806 | |
| Pubmed | 2.50e-05 | 25 | 240 | 4 | 23223237 | ||
| Pubmed | Dynamin genes Dnm1 and Dnm2 are located on proximal mouse chromosomes 2 and 9, respectively. | 2.64e-05 | 9 | 240 | 3 | 9143510 | |
| Pubmed | 2.64e-05 | 9 | 240 | 3 | 21035469 | ||
| Pubmed | 2.64e-05 | 9 | 240 | 3 | 7720210 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NUMBL XAB2 CSDE1 BTF3 ZBTB21 ANP32E PPP1R9B CAMSAP2 PLRG1 VCP DNM2 VIM ANK2 LIMD1 ARHGAP35 PDCD5 MACF1 PRKDC LRBA | 3.00e-05 | 934 | 240 | 19 | 33916271 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CSDE1 BTF3 MTMR2 HERC2 CAMSAP2 JCAD SHROOM3 LIMD1 HAUS5 FHIP2A ARHGAP5 CCT6A LATS1 AASS PPM1F CEP250 NINL GGA1 | 3.04e-05 | 853 | 240 | 18 | 28718761 |
| Pubmed | 3.21e-05 | 87 | 240 | 6 | 29991678 | ||
| Pubmed | SNX3 ANKRD27 EHD4 TGFBRAP1 EHD1 HEATR5B AP3B1 AP3B2 LRBA GGA1 | 3.23e-05 | 285 | 240 | 10 | 34369648 | |
| Pubmed | 3.43e-05 | 27 | 240 | 4 | 11156964 | ||
| Pubmed | 3.76e-05 | 10 | 240 | 3 | 19889638 | ||
| Pubmed | 3.76e-05 | 10 | 240 | 3 | 24963847 | ||
| Pubmed | Regulation of arrestin-3 phosphorylation by casein kinase II. | 3.76e-05 | 10 | 240 | 3 | 11877451 | |
| Pubmed | 3.82e-05 | 233 | 240 | 9 | 29518331 | ||
| Pubmed | 3.95e-05 | 234 | 240 | 9 | 36243803 | ||
| Interaction | YWHAH interactions | TET2 DLGAP1 PDE3B ABCA2 CEBPB NUMBL RPS6KA1 ZC3H13 IRS1 LYST ANKRD27 SBF1 PIK3C2B BTF3 ZBTB21 PPP1R9B HERC1 CAMSAP2 WNK3 VCP KIF13B VIM JCAD TICRR NSUN4 SHROOM3 LIMD1 HUWE1 MADD LATS1 ARRB2 MTOR PHF3 AASS NINL MACF1 LRBA PLCH1 | 2.28e-09 | 1102 | 237 | 38 | int:YWHAH |
| Interaction | YWHAG interactions | TET2 DLGAP1 PDE3B SNX3 CEBPB NUMBL RPS6KA1 ZC3H13 IRS1 LYST SBF1 PIK3C2B PIK3R1 BTF3 ZBTB21 PPP1R9B CAMSAP2 VCP KIF13B VIM JCAD TICRR SHROOM3 LIMD1 HUWE1 SHANK3 LATS1 ARRB2 RNH1 MTOR PHF3 AASS CEP250 NINL MACF1 PRKDC LRBA PLCH1 KIF13A | 2.06e-08 | 1248 | 237 | 39 | int:YWHAG |
| Interaction | YWHAZ interactions | TET2 DLGAP1 PDE3B PDE4D CEBPB NUMBL IRS1 NEB LYST GFAP ANKRD27 ADRA2A SBF1 PIK3C2B PIK3R1 BTF3 ZBTB21 PPP1R9B HERC2 CAMSAP2 VCP KIF13B VIM JCAD TICRR SHROOM3 RASGRF2 ARHGEF18 HUWE1 AP3B1 SHANK3 MADD LATS1 MTOR PHF3 AASS CTNNA3 MACF1 ATM PLCH1 | 3.00e-08 | 1319 | 237 | 40 | int:YWHAZ |
| Interaction | YWHAB interactions | TET2 DLGAP1 PDE3B CEBPB NUMBL RPS6KA1 IRS1 NEB LYST PIK3C2B BTF3 ZBTB21 PPP1R9B FGFR3 CAMSAP2 VCP AGAP2 KIF13B VIM TICRR SHROOM3 POLD1 SKP2 SHANK3 LATS1 ARRB2 RNH1 MTOR PHF3 AASS NINL MACF1 PLCH1 | 1.15e-07 | 1014 | 237 | 33 | int:YWHAB |
| Interaction | YWHAQ interactions | TET2 DLGAP1 PDE3B CEBPB NUMBL RPS6KA1 ZC3H13 IRS1 NEB LYST DES SBF1 PIK3C2B BTF3 ZBTB21 CAMSAP2 VCP KIF13B VIM JCAD TICRR SHROOM3 CPS1 SHANK3 CCT6A LATS1 ARRB2 RNH1 MTOR AASS CEP250 MACF1 PRKDC LRBA PLCH1 | 1.16e-07 | 1118 | 237 | 35 | int:YWHAQ |
| Interaction | EEF1AKMT3 interactions | DCAKD SNX3 RPS6KA2 WDR81 ANKRD27 XAB2 EHD4 NCAPG SBF1 PDZD8 ASCC3 HERC1 POLD1 HAUS5 HUWE1 PLCD3 CCT6A PDCD5 | 3.39e-07 | 364 | 237 | 18 | int:EEF1AKMT3 |
| Interaction | GNB1 interactions | DLGAP1 CEBPB ADRA2A PIK3R1 PPP1R9B MCF2L AGAP2 POLD1 ARHGEF18 SHANK3 RYBP CCT6A ARRB2 MTOR EXD2 CTNNA3 | 7.80e-07 | 307 | 237 | 16 | int:GNB1 |
| Interaction | CLTC interactions | TET2 ABCA2 CEBPB ITGB3 EHD4 BTF3 EHD1 PPP1R9B HERC2 HERC1 WNK3 VCP DNM2 AGAP2 VIM HUWE1 AP3B1 CCT6A ARRB2 RNH1 AP3B2 NINL LRBA GGA1 | 9.15e-07 | 655 | 237 | 24 | int:CLTC |
| Interaction | KCTD13 interactions | ENPP6 DLGAP1 PDE4D ATP6AP1 NUMBL TMOD2 PLD3 GFAP EHD3 CSDE1 SBF1 EHD1 MTMR2 KCNQ3 TLN2 PPP1R9B LRRC7 CAMSAP2 VCP DNM2 AGAP2 KPNA3 VIM MICAL1 CACNB4 ANK2 ARHGAP35 AP3B1 OMG SHANK3 MADD PITPNM1 ARHGAP5 CCT6A MICAL2 AP3B2 MACF1 PLCH1 | 1.02e-06 | 1394 | 237 | 38 | int:KCTD13 |
| Interaction | AGAP2 interactions | DLGAP1 NUMBL PIK3R1 TLN2 PPP1R9B LRRC7 AGAP2 ANK2 ARHGEF18 SHANK3 PITPNM1 PHF3 MACF1 | 1.30e-06 | 210 | 237 | 13 | int:AGAP2 |
| Interaction | ANK2 interactions | 2.34e-06 | 98 | 237 | 9 | int:ANK2 | |
| Interaction | PPP1CA interactions | DLGAP1 CEBPB DES NEK2 BTF3 PPP1R9B LRRC7 HERC2 PLRG1 ASF1A VCP AGAP2 KIF13B TRIOBP HUWE1 SKP2 CCT6A LATS1 ZNF827 PPP1R16B NINL PRKDC ATM KIF13A | 2.63e-06 | 696 | 237 | 24 | int:PPP1CA |
| Interaction | RPS6KA2 interactions | CEBPB RPS6KA1 RPS6KA2 SBF1 PIK3R1 PPP1R9B KPNA3 SHROOM3 SHANK3 MACF1 IRGC PRKDC | 3.75e-06 | 196 | 237 | 12 | int:RPS6KA2 |
| Interaction | HDAC2 interactions | TET2 CEBPB ESS2 GATAD2A RPS6KA1 IRS1 ADARB1 SNAI3 PRDM1 CSDE1 JARID2 NCAPG BTF3 EHD1 HERC2 AIM2 VCP KPNA3 KPNA4 HUWE1 CPS1 CCT6A ARRB2 ZNF827 PRKDC LRBA PLCH1 | 3.93e-06 | 865 | 237 | 27 | int:HDAC2 |
| Interaction | LCOR interactions | ABCA2 CEBPB OBSCN JARID2 ASF1A KPNA3 KPNA4 TRIOBP THAP4 CCT6A MICAL2 MACF1 ATM | 6.22e-06 | 242 | 237 | 13 | int:LCOR |
| Interaction | SFN interactions | TET2 CEBPB IRS1 NEB LYST PIK3C2B ZBTB21 CAMSAP2 VCP KIF13B VIM JCAD SHROOM3 POLD1 LATS1 RNH1 MTOR PHF3 AASS NINL MACF1 PLCH1 KIF13A | 7.84e-06 | 692 | 237 | 23 | int:SFN |
| Interaction | BCAR1 interactions | TET2 ESS2 NUMBL RPS6KA1 COQ3 TTC9C XAB2 PIK3R1 BTF3 FGFR3 VCP HAUS5 SPTLC1 CHD7 IRGQ MTOR FLAD1 LRBA KIF13A GGA1 | 1.01e-05 | 556 | 237 | 20 | int:BCAR1 |
| Interaction | NES interactions | 1.31e-05 | 152 | 237 | 10 | int:NES | |
| Interaction | TOP3B interactions | STK36 ABCA2 CEBPB LRRC24 RPS6KA2 OBSCN TMCO6 IRS1 LYST ADCY9 CSDE1 SBF1 PIK3C2B PDZD8 TLN2 PPP1R9B HERC2 HERC1 MCF2L PLXNA3 SHROOM3 TSNARE1 HUWE1 MED13L ARHGAP35 ZBTB42 MADD PLCD3 CELSR2 ZNF827 MTOR BTBD7 NINL PRKDC LRBA GGA1 | 2.18e-05 | 1470 | 237 | 36 | int:TOP3B |
| Interaction | VIM interactions | TET2 CEBPB ESS2 IRS1 NEB ITGB3 GFAP DES NEK2 BTF3 PPP1R9B ASCC3 VCP TCEA2 VIM MICAL1 LIMD1 TRIOBP SHANK3 CCT6A ARRB2 RNH1 PRKDC XKR5 | 2.88e-05 | 804 | 237 | 24 | int:VIM |
| Interaction | YWHAE interactions | TET2 DLGAP1 PDE3B CEBPB NUMBL IRS1 LYST ANKRD27 SBF1 PIK3C2B PIK3R1 BTF3 ZBTB21 MTMR2 PPP1R9B CAMSAP2 VCP KIF13B VIM JCAD TICRR SHROOM3 HUWE1 SHANK3 LATS1 ARRB2 MTOR AASS CEP250 MACF1 LRBA PLCH1 | 3.09e-05 | 1256 | 237 | 32 | int:YWHAE |
| Interaction | TELO2 interactions | 3.20e-05 | 135 | 237 | 9 | int:TELO2 | |
| Interaction | MAP6 interactions | 3.35e-05 | 32 | 237 | 5 | int:MAP6 | |
| Interaction | KCNA3 interactions | DNAJB12 NUMBL ADCY9 EHD3 CSDE1 EHD1 PDZD8 TLN2 LRRC7 ASCC3 VCP VIM ANK2 MYH7B AP3B1 CCT6A LATS1 PHF3 AP3B2 CTNNA3 MACF1 CARD11 PRKDC LRBA PLCH1 | 3.72e-05 | 871 | 237 | 25 | int:KCNA3 |
| Interaction | FBXO41 interactions | 3.93e-05 | 17 | 237 | 4 | int:FBXO41 | |
| Interaction | SHANK2 interactions | 4.45e-05 | 55 | 237 | 6 | int:SHANK2 | |
| Interaction | SOCS1 interactions | 4.84e-05 | 177 | 237 | 10 | int:SOCS1 | |
| Interaction | HTR6 interactions | 6.03e-05 | 58 | 237 | 6 | int:HTR6 | |
| Interaction | LRRC7 interactions | 6.03e-05 | 58 | 237 | 6 | int:LRRC7 | |
| Interaction | SLC6A4 interactions | DLGAP1 GFAP SBF1 PPP1R9B LRRC7 HERC2 CAMSAP2 AGAP2 VIM DDR1 SHANK3 CEP250 DNAJC11 AP3B2 CTNNA3 MACF1 | 6.47e-05 | 437 | 237 | 16 | int:SLC6A4 |
| Interaction | XPA interactions | 6.95e-05 | 86 | 237 | 7 | int:XPA | |
| Interaction | USP18 interactions | 7.31e-05 | 60 | 237 | 6 | int:USP18 | |
| Interaction | CLTA interactions | TET2 CEBPB NUMBL PIK3R1 BTF3 PPP1R9B HERC2 HEATR5B WNK3 VCP AP3B1 SHANK3 ARRB2 GGA1 | 7.57e-05 | 351 | 237 | 14 | int:CLTA |
| Interaction | MAPK1 interactions | DLGAP1 PDE4D CEBPB RPS6KA1 RPS6KA2 IRS1 NEB NEK2 PPP1R9B VCP AGAP2 HUWE1 ZBTB42 SHANK3 ARRB2 MTOR PHF3 ATM | 8.14e-05 | 543 | 237 | 18 | int:MAPK1 |
| Interaction | WHAMMP3 interactions | 8.31e-05 | 119 | 237 | 8 | int:WHAMMP3 | |
| Interaction | MYH9 interactions | TET2 CEBPB ADARB1 ITGB3 NEK2 NCAPG BTF3 PDZD8 PPP1R9B VCP TCEA2 KIF13B VIM SHROOM3 TRIOBP HUWE1 ARRB2 RNH1 CIAO3 PHF3 CEP250 MACF1 | 8.77e-05 | 754 | 237 | 22 | int:MYH9 |
| Interaction | SHANK1 interactions | 1.14e-04 | 41 | 237 | 5 | int:SHANK1 | |
| Interaction | TPCN2 interactions | 1.15e-04 | 65 | 237 | 6 | int:TPCN2 | |
| Interaction | NEFL interactions | 1.25e-04 | 161 | 237 | 9 | int:NEFL | |
| Interaction | XKR5 interactions | 1.38e-04 | 2 | 237 | 2 | int:XKR5 | |
| Interaction | MAPK3 interactions | DLGAP1 CEBPB MYOG RPS6KA1 RPS6KA2 IRS1 TTC9C ITGB3 VCP AGAP2 VIM ZBTB42 SHANK3 ARRB2 PHF3 | 1.48e-04 | 421 | 237 | 15 | int:MAPK3 |
| Interaction | RBBP4 interactions | CDK20 CEBPB GATAD2A ANKRD27 JARID2 NCAPG BTF3 ASCC3 ASF1A VCP KPNA3 KPNA4 POLD1 CHD7 HUWE1 RYBP ZNF827 CEP250 | 1.59e-04 | 573 | 237 | 18 | int:RBBP4 |
| Interaction | CTPS2 interactions | 1.62e-04 | 131 | 237 | 8 | int:CTPS2 | |
| Interaction | DNAJC7 interactions | DNAJB12 CEBPB ADCY9 EHD4 SBF1 HERC2 ASCC3 POLD1 HUWE1 CPS1 SHANK3 DNAJC11 PRKDC ATM LAS1L | 1.64e-04 | 425 | 237 | 15 | int:DNAJC7 |
| Interaction | NME3 interactions | 1.80e-04 | 100 | 237 | 7 | int:NME3 | |
| Interaction | KCNE3 interactions | ABCA2 SNX3 NEK2 SBF1 PIK3R1 DDR1 PLCD3 LRR1 ARRB2 LRBA PLCH1 FIGNL1 | 2.12e-04 | 296 | 237 | 12 | int:KCNE3 |
| Interaction | FMR1 interactions | SMG1 DLGAP1 NUMBL EHD3 CSDE1 CNTNAP5 BTF3 HERC2 CAMSAP2 PLRG1 AGAP2 CACNB4 ARHGEF18 CHD7 ZBTB42 SHANK3 MACF1 | 2.17e-04 | 536 | 237 | 17 | int:FMR1 |
| Interaction | ERBB2 interactions | DNAJB12 ATP6AP1 IRS1 PLD3 CSDE1 PIK3C2B PIK3R1 LRRC7 FGFR3 DDR1 FLT3 SPTLC1 SLC7A4 PPM1F AP3B2 NINL PRKDC MUC4 | 2.23e-04 | 589 | 237 | 18 | int:ERBB2 |
| Interaction | SIPA1L1 interactions | 2.25e-04 | 174 | 237 | 9 | int:SIPA1L1 | |
| Interaction | KIF21A interactions | 2.44e-04 | 105 | 237 | 7 | int:KIF21A | |
| Interaction | DYNC1H1 interactions | CEBPB ITGB3 CSDE1 BTF3 PPP1R9B FGFR3 PLRG1 VCP AGAP2 FLT3 SPTLC1 HUWE1 SHANK3 ARRB2 NINL PRKDC | 2.46e-04 | 491 | 237 | 16 | int:DYNC1H1 |
| Interaction | GSK3B interactions | PDE4D CEBPB RPS6KA1 IRS1 CSDE1 BTF3 HERC2 ASCC3 CAMSAP2 VCP AGAP2 VIM MICAL1 LIMD1 HAUS5 TRIOBP ARHGAP35 SHANK3 CCT6A ARRB2 MTOR MACF1 PRKDC | 2.48e-04 | 868 | 237 | 23 | int:GSK3B |
| Interaction | SPRTN interactions | TTC9C EHD4 DES NAA25 VCP DNM2 KPNA4 VIM POLD1 SPTLC1 HUWE1 CPS1 CCT6A PPM1F DNAJC11 PRKDC LAS1L FIGNL1 | 2.57e-04 | 596 | 237 | 18 | int:SPRTN |
| Interaction | RCOR1 interactions | CEBPB GATAD2A PRDM1 NCAPG ZBTB21 ASCC3 VCP CCDC93 CHD7 HUWE1 RBM20 ARRB2 ZNF827 NINL LRBA PHF13 | 2.63e-04 | 494 | 237 | 16 | int:RCOR1 |
| GeneFamily | Intermediate filaments Type III | 6.10e-06 | 5 | 155 | 3 | 610 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 5.00e-05 | 9 | 155 | 3 | 1230 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.28e-05 | 206 | 155 | 9 | 682 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.55e-04 | 66 | 155 | 5 | 722 | |
| GeneFamily | Dyneins, axonemal | 3.85e-04 | 17 | 155 | 3 | 536 | |
| GeneFamily | PDZ domain containing | 2.00e-03 | 152 | 155 | 6 | 1220 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | STK36 PDE3B ABCA2 ZC3H13 TMOD2 SLC12A8 TTC9C GAL3ST3 ANP32E HERC1 WNK3 SLC66A3 TICRR ANK2 CHD7 MADD ZNF711 ARHGAP5 ARRB2 CELSR2 PPP1R16B CKAP2L MACF1 ATM PLCH1 CCDC17 FIGNL1 XKR5 LIX1 | 7.29e-06 | 1060 | 236 | 29 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | alpha beta T cells, T.8SP24int.Th, 4- 8+ TCRhi 24int, Thymus, avg-3 | PDE3B PDE4D PLD3 SNAI3 EHD3 NCAPG DNAH8 MAP4K2 TICRR CDH24 ZNF827 PPP1R16B ATM FIGNL1 | 2.85e-05 | 339 | 236 | 14 | GSM399382_500 |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.32e-09 | 184 | 240 | 11 | fea4fe648e9749177d0783443dc26a7df5807883 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.32e-09 | 184 | 240 | 11 | 96a8a0a190bc293655fe7d80cbed8119c0da25f2 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.32e-09 | 184 | 240 | 11 | 780eb72da43527f0c72effac3423ec7384f05f20 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | CDK20 PDE4D LRRC43 PRDM1 PIK3R1 MINAR1 VIM RASGRF2 MAGEE1 CDH24 | 2.21e-08 | 164 | 240 | 10 | 8f3255d7f67890389a768453492243ea982eb38a |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | STK36 WDR81 PIK3C2B POLD1 HAUS5 HIF3A SHANK3 PPM1F CEP250 PHF13 | 8.45e-08 | 189 | 240 | 10 | bccb3481ffed597c845fe860da658505316105b5 |
| ToppCell | Ionocyte-iono-3|World / Class top | 3.08e-07 | 166 | 240 | 9 | 9c4a780f8af46d7552077c7a0ae0ab1b2413e5d4 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 3.76e-07 | 170 | 240 | 9 | 9e328e1f904c77dcce8aee4df775d7f0ac725775 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.99e-07 | 191 | 240 | 9 | 44c596984c6196f6014e0e405dbe5560841e54ff | |
| ToppCell | E16.5-samps-Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.99e-07 | 191 | 240 | 9 | e7521d4d24f016d4e531cd492a7a69604f0c9e6f | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-06 | 192 | 240 | 9 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 195 | 240 | 9 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 195 | 240 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 195 | 240 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.24e-06 | 196 | 240 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-06 | 196 | 240 | 9 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 198 | 240 | 9 | a7e5de81eb7d3d23812c179a001adbaab1506596 | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_only / Treatment groups by lineage, cell group, cell type | 1.40e-06 | 199 | 240 | 9 | b62a756b5472972156d05051a58671a58bef1f16 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-ILC|IIF / Disease, condition lineage and cell class | 1.46e-06 | 200 | 240 | 9 | edb0b252e6ff9824908d1ff7d0d42710b00949c8 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.86e-06 | 153 | 240 | 8 | 69a8550418ba0fc908a84b3b85761abb6e8ca4c0 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.86e-06 | 153 | 240 | 8 | e50d20f9e553b8c3e10e187770d8abe1a43d109e | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.86e-06 | 153 | 240 | 8 | d7635f3d4831c02a94f53afc674847d5b51453be | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.86e-06 | 153 | 240 | 8 | 54a941950bbb848077c7bd5726da9e4b3244bd38 | |
| ToppCell | IIF-Lymphocyte-T_NK-ILC|IIF / Disease, Lineage and Cell Type | 2.47e-06 | 159 | 240 | 8 | 55e4f21548f480ca414c00cbff5ec3b13bafd271 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-06 | 171 | 240 | 8 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-06 | 171 | 240 | 8 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.25e-06 | 176 | 240 | 8 | a84361308e5e96f3a30246cd29e109c321ee65bf | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-06 | 176 | 240 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.25e-06 | 176 | 240 | 8 | d70fdc7bc48719776ed1e7c01118385e3a21623f | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-06 | 179 | 240 | 8 | 804aa3899585fc7e662eff9f6d41f48655f16dd6 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 6.19e-06 | 180 | 240 | 8 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-06 | 182 | 240 | 8 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.71e-06 | 182 | 240 | 8 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 184 | 240 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 184 | 240 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 184 | 240 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.87e-06 | 186 | 240 | 8 | 5916ee851c17d6d9adefeea900b4dfa9642982dc | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.85e-06 | 189 | 240 | 8 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.85e-06 | 189 | 240 | 8 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.85e-06 | 189 | 240 | 8 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.85e-06 | 189 | 240 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.19e-06 | 190 | 240 | 8 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.19e-06 | 190 | 240 | 8 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.92e-06 | 192 | 240 | 8 | 1a3f24607cb49aa610c183f4c2b7d735f484a3a4 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.92e-06 | 192 | 240 | 8 | c8dcd75d695d09adff083af8d5a64cf15fe027d4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-05 | 193 | 240 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-05 | 194 | 240 | 8 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 194 | 240 | 8 | 74a9fdb73f279bebb6337510deab9aaaf9f7e957 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 194 | 240 | 8 | e55dc30e200c9f576804acb642175eb4fa9146b5 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC2|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-05 | 140 | 240 | 7 | c3331cb7720f93af8bab35d02c6cbe87dd324d91 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.11e-05 | 195 | 240 | 8 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 196 | 240 | 8 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 196 | 240 | 8 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 197 | 240 | 8 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.20e-05 | 197 | 240 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.20e-05 | 197 | 240 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-05 | 198 | 240 | 8 | 604fb20ca1aaf8f07067a8e1593a30ba335891f7 | |
| ToppCell | (03)_KRT6B+-(1)_GFP|(03)_KRT6B+ / shred by cell type by condition | 1.29e-05 | 199 | 240 | 8 | 10493933a3dc330e40595ec0c001428b9d68f17e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.29e-05 | 199 | 240 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 199 | 240 | 8 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | 6a34e07e6d77fe3fdd9ff44c4b1e46a023f6d6a2 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-05 | 150 | 240 | 7 | c3ad5fa41eb636a5d691c0268c0f1c32cd0de658 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.73e-05 | 150 | 240 | 7 | 6f7087a051a2f05c5611ff65a945c01736d5ec2b | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-05 | 150 | 240 | 7 | 78b8029e71d26f336a46274c8afef3435bf536b9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.81e-05 | 151 | 240 | 7 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 152 | 240 | 7 | 7e686721b95c837f2b0d5116927c8ecacef055ee | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 154 | 240 | 7 | 5ed64bbf603290e6dc34f81d145982690b89dd0d | |
| ToppCell | Goblet-gob-1|World / Class top | 2.52e-05 | 159 | 240 | 7 | 62d4ca2b538382419252e306d7a789b64420fb18 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.73e-05 | 161 | 240 | 7 | b19f82dd98a3064581793711bb70373f18abecd9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 161 | 240 | 7 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 161 | 240 | 7 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.96e-05 | 163 | 240 | 7 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-05 | 163 | 240 | 7 | 2d6fd2562d78be9f83fa35d811eb7e27eb8cc5d1 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 165 | 240 | 7 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.02e-05 | 171 | 240 | 7 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.17e-05 | 172 | 240 | 7 | d65ffff3e341af34a043a0d802d7ba4b69de36e9 | |
| ToppCell | COVID-19_Mild-Neu_2|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 4.17e-05 | 172 | 240 | 7 | f5fd08b42c002d4693646b27e7b708eceb49524f | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 172 | 240 | 7 | 65b8935a972bf00b7a10dc2d442128fc0ed78bcb | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 174 | 240 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 4.49e-05 | 174 | 240 | 7 | 5ec8a48a390379d6c422120dce46437a77da67cc | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.65e-05 | 175 | 240 | 7 | 16d4e97271df1db9a0d167fc82a90d84d20dd1f2 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.65e-05 | 175 | 240 | 7 | 553e68e8b439a2293efb969e1e2aa017ceb80daf | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.65e-05 | 175 | 240 | 7 | 289d2aa7164bc02b1876b99f2fb67baa8e030c4e | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 4.82e-05 | 176 | 240 | 7 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 178 | 240 | 7 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-05 | 179 | 240 | 7 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 180 | 240 | 7 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 180 | 240 | 7 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | Severe-Lymphoid-B-|Severe / Condition, Lineage, Cell class and cell subclass | 5.56e-05 | 180 | 240 | 7 | fd3eb751704b14ff1500e4bd041441644d233e9c | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 180 | 240 | 7 | 87347af8f28cf7c486c19f3f98c0afb022c323b5 | |
| ToppCell | Severe-Lymphoid-B|Severe / Condition, Lineage, Cell class and cell subclass | 5.56e-05 | 180 | 240 | 7 | 67ffaf5096f025c3c61fffe52f6c8a96f120fc6f | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 180 | 240 | 7 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 180 | 240 | 7 | 78fdcfb3fdbf36469cae78407cda5bd0996930d8 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Control / Disease condition and Cell class | 5.76e-05 | 181 | 240 | 7 | f3e1d8fe5cf1eba19e51c3680a55306cae687fe9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 5.76e-05 | 181 | 240 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-05 | 182 | 240 | 7 | 1e2149b222a3e9f64841aed45288a6f29394e7b0 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.96e-05 | 182 | 240 | 7 | 7af3b2029b7f55b923d5a4b764d4292f4ea48599 | |
| ToppCell | E18.5-samps-Endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.96e-05 | 182 | 240 | 7 | e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.98e-05 | 125 | 240 | 6 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | Severe_COVID-19-B_cell-B_cell|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.17e-05 | 183 | 240 | 7 | 5634e528001c389efd1e380f01ad40072f60e943 | |
| ToppCell | Control-T/NK-proliferating_T/NK|Control / Disease group,lineage and cell class (2021.01.30) | 6.17e-05 | 183 | 240 | 7 | e740f05536d1e4b2512811771928eb65f6696409 | |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; HL60; HT_HG-U133A | DCAKD ESS2 TMCO6 LYST MTMR2 CAMSAP2 HAUS5 TFR2 CIAO3 PPM1F BTBD7 CEP250 | 1.09e-06 | 197 | 236 | 12 | 3070_DN |
| Drug | Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | DNAJB12 PLD3 ADCY9 SBF1 MTMR2 HAUS5 TRIOBP ARRB2 MTOR MICAL2 MACF1 GGA1 | 1.15e-06 | 198 | 236 | 12 | 7235_DN |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | PDE3B ABCA2 TMCO6 PIK3R1 FGFR3 POLD1 HAUS5 MICAL2 CEP250 MACF1 GGA1 | 4.31e-06 | 187 | 236 | 11 | 1656_DN |
| Drug | DFT-D | 5.22e-06 | 12 | 236 | 4 | CID000124866 | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | EHD1 MINAR1 PLXNA3 VIM HAUS5 ARHGAP35 PITPNM1 PPM1F BTBD7 ATM PLCH1 | 6.13e-06 | 194 | 236 | 11 | 3422_UP |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; PC3; HT_HG-U133A | RSPH14 PDE4D XAB2 SBF1 TLN2 PLXNA3 MICAL1 ARHGAP35 SKP2 MTOR PHF3 | 7.09e-06 | 197 | 236 | 11 | 4207_DN |
| Drug | NS-398; Up 200; 10uM; PC3; HT_HG-U133A | IL11 PDE4D RPS6KA2 ADARB1 LYST DES FLT3 CPS1 AP3B1 AASS DNAH17 | 7.44e-06 | 198 | 236 | 11 | 6892_UP |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | DCAKD ABCA2 NEB LYST SBF1 HAUS5 SKP2 CGREF1 PPM1F BTBD7 PLCH1 | 7.44e-06 | 198 | 236 | 11 | 3421_DN |
| Drug | Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; HL60; HT_HG-U133A | DCAKD RSPH14 PDE4D ZC3H13 SLC12A8 DNM2 ARHGAP35 OMG TFR2 LATS1 GGA1 | 7.44e-06 | 198 | 236 | 11 | 2909_UP |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A | RPS6KA2 TGFBRAP1 EHD1 FGFR3 PLXNA3 MICAL1 TRIOBP MTOR CEP250 ATM LRBA | 7.81e-06 | 199 | 236 | 11 | 1702_DN |
| Drug | Amiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | CDK20 DNAJB12 ABCA2 RPS6KA2 NEB ADARB1 ITIH2 DES ARRB2 BTBD7 ATM | 7.81e-06 | 199 | 236 | 11 | 4119_DN |
| Drug | Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; PC3; HT_HG-U133A | 8.19e-06 | 200 | 236 | 11 | 6676_DN | |
| Drug | AD 288 | 1.04e-05 | 14 | 236 | 4 | CID000073553 | |
| Drug | A61603 | 2.15e-05 | 33 | 236 | 5 | CID004038180 | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; PC3; HT_HG-U133A | DNAJB12 DES FGFR3 KERA HIF3A HUWE1 ARHGAP35 SKP2 TFR2 BRINP2 | 3.53e-05 | 193 | 236 | 10 | 5922_DN |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.53e-05 | 193 | 236 | 10 | 2209_UP | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; PC3; HT_HG-U133A | 3.53e-05 | 193 | 236 | 10 | 2049_DN | |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 3.69e-05 | 194 | 236 | 10 | 4178_DN | |
| Drug | Indoprofen [31842-01-0]; Up 200; 14.2uM; MCF7; HT_HG-U133A | PDE3B RPS6KA2 MAP4K2 AGAP2 VEZT HIF3A LATS1 BTBD7 DNAH17 ATM | 3.69e-05 | 194 | 236 | 10 | 3345_UP |
| Drug | 2f4b | 3.86e-05 | 19 | 236 | 4 | CID006102812 | |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A | ABCA2 SLC12A8 ADARB1 XAB2 TGFBRAP1 TRIOBP SKP2 PITPNM1 MTOR ATM | 4.02e-05 | 196 | 236 | 10 | 2755_DN |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; HL60; HT_HG-U133A | ABCA2 SLC12A8 NEB DES TGFBRAP1 CAMSAP2 CCDC93 ARHGAP35 SKP2 TFR2 | 4.20e-05 | 197 | 236 | 10 | 2171_DN |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | ABCA2 ADCY9 XAB2 EHD1 TLN2 ARHGAP35 AP3B1 SKP2 CELSR2 KIF13A | 4.20e-05 | 197 | 236 | 10 | 4336_DN |
| Drug | Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | FGD1 MCF2L PLXNA3 HAUS5 ARHGAP35 ARRB2 MICAL2 BTBD7 CEP250 PLCH1 | 4.20e-05 | 197 | 236 | 10 | 3308_DN |
| Drug | C75; Up 200; 10uM; PC3; HT_HG-U133A | CDK20 DCAKD RSPH14 PDE4D KDM5D KCNQ3 TLN2 TFR2 DNAH17 BRINP2 | 4.20e-05 | 197 | 236 | 10 | 6399_UP |
| Drug | Sulfaquinoxaline sodium salt [967-80-6]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 4.38e-05 | 198 | 236 | 10 | 6788_UP | |
| Drug | Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 4.57e-05 | 199 | 236 | 10 | 6804_UP | |
| Drug | Antimycin A [1397-94-0]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 4.57e-05 | 199 | 236 | 10 | 5472_DN | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; PC3; HT_HG-U133A | IL11 PIK3R1 TLN2 HAUS5 TRIOBP ARHGAP35 SKP2 LATS1 CIAO3 PHF3 | 4.57e-05 | 199 | 236 | 10 | 5048_DN |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | PDE3B RPS6KA2 SBF1 CCDC93 HAUS5 ARHGAP35 AP3B1 SKP2 ARHGAP5 ATM | 4.57e-05 | 199 | 236 | 10 | 4803_DN |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A | PDE3B ZC3H13 TMOD2 SLC12A8 ITIH2 AGAP2 PHF3 CEP250 BRINP2 LSP1 | 4.77e-05 | 200 | 236 | 10 | 3833_UP |
| Drug | AC1OAGFB | TMOD2 IRS1 PLD3 ITGB3 ADCY9 ACTL7A PIK3C2B PIK3R1 KCNQ3 HERC1 DNM2 AGAP2 ARHGAP35 PLCD3 MTOR CARD11 PLCH1 | 5.15e-05 | 539 | 236 | 17 | CID006857345 |
| Drug | orthovanadate | ENPP6 PDE3B PDE4D ATP6AP1 IRS1 PLD3 ADCY9 SBF1 PIK3R1 KIF13B DNAH1 SCARA5 DNAH17 LRBA KIF13A | 5.31e-05 | 435 | 236 | 15 | CID000061672 |
| Drug | mono-(2-ethylhexyl)phthalate | PDE4D CEBPB SLC12A8 IRS1 KDM5D NEB ITGB3 GALNT13 JARID2 CNTNAP5 DHRS4 ASCC3 DNAH8 VIM RASGRF2 GDPD4 ARRB2 CELSR2 SCG3 | 6.11e-05 | 658 | 236 | 19 | ctd:C016599 |
| Drug | guanine | PLD3 ANKRD27 ADCY9 DHRS4 ADRA2A FGD1 HERC1 MCF2L GTPBP3 AGAP2 KIF13B RASGRF2 ARHGEF18 ARHGAP35 MADD PLCD3 ARRB2 RNH1 MTOR RRAGA LRBA PLCH1 GGA1 | 6.95e-05 | 902 | 236 | 23 | CID000000764 |
| Drug | 9-beta-D-arabinofuranosylguanine | PDE3B PDE4D PLD3 ADARB1 GFAP ADCY9 ACTL7A NCAPG PIK3R1 ANP32E MCF2L GTPBP3 DNM2 AGAP2 POLD1 ARHGEF18 OMG ADO MTOR CARD11 LRBA PLCH1 | 7.18e-05 | 843 | 236 | 22 | CID000000765 |
| Drug | phenylisopropyladenosine | 8.77e-05 | 70 | 236 | 6 | CID000005022 | |
| Drug | ZSTK474 | 8.82e-05 | 9 | 236 | 3 | ctd:C510150 | |
| Drug | everolimus | 8.92e-05 | 136 | 236 | 8 | CID006442177 | |
| Drug | Cloethocarb | 9.99e-05 | 45 | 236 | 5 | CID000040032 | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.00e-04 | 177 | 236 | 9 | 1069_DN | |
| Drug | 6-fluorocholesterol | 1.07e-04 | 2 | 236 | 2 | CID000135206 | |
| Drug | 25-fluorocholesterol | 1.07e-04 | 2 | 236 | 2 | CID006454807 | |
| Drug | CM 40876 | 1.07e-04 | 2 | 236 | 2 | CID009578292 | |
| Drug | Proscillaridin A [466-06-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A | PIK3C2B C7orf25 PIK3R1 TGFBRAP1 TLN2 SKP2 PPM1F FLAD1 CEP250 | 1.09e-04 | 179 | 236 | 9 | 4404_DN |
| Drug | Etilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; HL60; HT_HG-U133A | 1.19e-04 | 181 | 236 | 9 | 2930_UP | |
| Drug | AC1OAGFW | 1.35e-04 | 184 | 236 | 9 | CID006857352 | |
| Drug | Anisomycin [22862-76-6]; Down 200; 15uM; PC3; HT_HG-U133A | 1.52e-04 | 187 | 236 | 9 | 6764_DN | |
| Drug | celastrol; Down 200; 2.5uM; MCF7; HT_HG-U133A_EA | 1.52e-04 | 187 | 236 | 9 | 887_DN | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.65e-04 | 189 | 236 | 9 | 2790_DN | |
| Drug | AC1NST48 | SNX3 ATP6AP1 PLD3 LYST ACTL7A HERC1 DNM2 AGAP2 COG7 XBP1 KERA AP3B1 TFR2 MTOR AP3B2 LRBA GGA1 | 1.66e-04 | 594 | 236 | 17 | CID005315496 |
| Drug | 17-hydroxywortmannin | 1.71e-04 | 11 | 236 | 3 | CID000130966 | |
| Drug | Bisacodyl [603-50-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.72e-04 | 190 | 236 | 9 | 3297_DN | |
| Drug | milrinone | 1.76e-04 | 150 | 236 | 8 | CID000004197 | |
| Drug | Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; PC3; HT_HG-U133A | DNAJB12 PDE3B RSPH14 RPS6KA2 PIK3R1 AIM2 PCYT1B ARHGAP35 MICAL2 | 1.78e-04 | 191 | 236 | 9 | 6693_UP |
| Drug | Digitoxigenin [143-62-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.86e-04 | 192 | 236 | 9 | 4801_DN | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.86e-04 | 192 | 236 | 9 | 1068_DN | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.93e-04 | 193 | 236 | 9 | 4138_DN | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; MCF7; HT_HG-U133A | 1.93e-04 | 193 | 236 | 9 | 4125_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.93e-04 | 193 | 236 | 9 | 5291_DN | |
| Drug | Methazolamide [554-57-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 2.01e-04 | 194 | 236 | 9 | 3474_DN | |
| Drug | Phensuximide [86-34-0]; Down 200; 21.2uM; MCF7; HT_HG-U133A | 2.01e-04 | 194 | 236 | 9 | 3521_DN | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.01e-04 | 194 | 236 | 9 | 5297_DN | |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.01e-04 | 194 | 236 | 9 | 4492_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.01e-04 | 194 | 236 | 9 | 6171_DN | |
| Drug | Dirithromycin [62013-04-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 2.01e-04 | 194 | 236 | 9 | 2863_UP | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 2.01e-04 | 194 | 236 | 9 | 3431_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A | 2.08e-04 | 195 | 236 | 9 | 3812_DN | |
| Drug | Fendiline hydrochloride [13636-18-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.08e-04 | 195 | 236 | 9 | 7188_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.08e-04 | 195 | 236 | 9 | 2208_DN | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; PC3; HT_HG-U133A | 2.08e-04 | 195 | 236 | 9 | 4250_DN | |
| Drug | Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.16e-04 | 196 | 236 | 9 | 6483_UP | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.16e-04 | 196 | 236 | 9 | 4772_UP | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.16e-04 | 196 | 236 | 9 | 7312_DN | |
| Drug | Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; PC3; HT_HG-U133A | 2.16e-04 | 196 | 236 | 9 | 1807_DN | |
| Drug | monastrol; Down 200; 100uM; MCF7; HG-U133A | 2.16e-04 | 196 | 236 | 9 | 627_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 2.16e-04 | 196 | 236 | 9 | 1666_UP | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; HL60; HT_HG-U133A | 2.16e-04 | 196 | 236 | 9 | 2351_DN | |
| Drug | Netilmicin sulfate [56931-57-2]; Down 200; 2.8uM; HL60; HT_HG-U133A | 2.16e-04 | 196 | 236 | 9 | 2963_DN | |
| Drug | Zardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.16e-04 | 196 | 236 | 9 | 4793_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.16e-04 | 196 | 236 | 9 | 3441_UP | |
| Drug | Dydrogesterone [152-62-5]; Up 200; 12.8uM; HL60; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 2156_UP | |
| Drug | Fenbendazole [43210-67-9]; Up 200; 13.4uM; HL60; HT_HG-U133A | DNAJB12 RSPH14 SLC12A8 EHD1 MINAR1 CAMSAP2 CPS1 CEP250 PPP1R16B | 2.25e-04 | 197 | 236 | 9 | 2360_UP |
| Drug | clozapine; Down 200; 10uM; HL60; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 2689_DN | |
| Drug | Ribavirin [36791-04-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 6018_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 6727_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 2124_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 4717_DN | |
| Drug | Hymecromone [90-33-5]; Up 200; 22.8uM; MCF7; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 5684_UP | |
| Drug | Nifurtimox [23256-30-6]; Up 200; 14uM; HL60; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 2908_UP | |
| Drug | Sulfameter [651-06-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 3453_UP | |
| Drug | A-Cw | 2.26e-04 | 12 | 236 | 3 | CID013891726 | |
| Drug | glycogen | CEBPB RPS6KA1 RPS6KA2 IRS1 COQ3 GFAP DES PIK3R1 PCYT1B VIM MTOR TREH AASS LRBA | 2.33e-04 | 443 | 236 | 14 | CID000439177 |
| Drug | Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.33e-04 | 198 | 236 | 9 | 1533_DN | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.33e-04 | 198 | 236 | 9 | 6395_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A | 2.33e-04 | 198 | 236 | 9 | 4464_DN | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 2.33e-04 | 198 | 236 | 9 | 2256_DN | |
| Drug | Bucladesine sodium salt [16980-89-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | DNAJB12 PDE3B SLC12A8 C7orf25 EHD1 PITPNM1 ARRB2 CGREF1 PLCH1 | 2.33e-04 | 198 | 236 | 9 | 3483_DN |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.33e-04 | 198 | 236 | 9 | 2651_DN | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.33e-04 | 198 | 236 | 9 | 1701_DN | |
| Disease | Schizophrenia | DLGAP1 PDE4D ESS2 NUMBL ADARB1 ITGB3 GFAP JARID2 ADRA2A KCNQ3 PPP1R9B WNK3 KPNA3 DDR1 TSNARE1 XBP1 SHANK3 RHD PITPNM1 MTOR ATM EN1 | 2.47e-06 | 883 | 234 | 22 | C0036341 |
| Disease | oral squamous cell carcinoma (is_marker_for) | 1.09e-05 | 63 | 234 | 6 | DOID:0050866 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | OBSCN DES NAA25 LRRC7 HERC2 AGAP2 VIM MICAL1 ANK2 RASGRF2 SPTLC1 XBP1 SIM1 MAGEE1 RHD MTOR PPM1F MACF1 LSP1 ATM LRBA GGA1 | 5.05e-05 | 1074 | 234 | 22 | C0006142 |
| Disease | cancer antigen 125 measurement | 5.67e-05 | 10 | 234 | 3 | EFO_0010603 | |
| Disease | bladder urothelial carcinoma (is_marker_for) | 6.26e-05 | 2 | 234 | 2 | DOID:4006 (is_marker_for) | |
| Disease | lymphocyte count | TET2 PDE4D RPS6KA1 UROC1 PLD3 LYST ADCY9 JARID2 PIK3R1 KPNA3 TCEA2 JCAD FLT3 XBP1 ARHGEF18 CHD7 HIF3A MED13L CPS1 TFR2 ARRB2 ADO DNAH17 LSP1 CARD11 ATM | 1.10e-04 | 1464 | 234 | 26 | EFO_0004587 |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 1.33e-04 | 13 | 234 | 3 | C3501611 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 2.09e-04 | 15 | 234 | 3 | C0496930 | |
| Disease | Benign neoplasm of bladder | 2.09e-04 | 15 | 234 | 3 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 2.09e-04 | 15 | 234 | 3 | C0154091 | |
| Disease | Intellectual Disability | SNX3 UROC1 CSDE1 PTCHD1 ASCC3 MED13L FHIP2A SHANK3 MTOR AASS MACF1 LAS1L | 2.60e-04 | 447 | 234 | 12 | C3714756 |
| Disease | oral motor function measurement | 3.08e-04 | 17 | 234 | 3 | EFO_0021793 | |
| Disease | cancer (implicated_via_orthology) | 3.10e-04 | 268 | 234 | 9 | DOID:162 (implicated_via_orthology) | |
| Disease | total hip arthroplasty, osteoarthritis | 3.41e-04 | 42 | 234 | 4 | EFO_0009806, MONDO_0005178 | |
| Disease | Carcinoma of bladder | 3.68e-04 | 18 | 234 | 3 | C0699885 | |
| Disease | Coffin-Lowry syndrome (implicated_via_orthology) | 3.72e-04 | 4 | 234 | 2 | DOID:3783 (implicated_via_orthology) | |
| Disease | X-17325 measurement | 3.72e-04 | 4 | 234 | 2 | EFO_0800771 | |
| Disease | Prostatic Neoplasms | TET2 PDE4D IRS1 TTC9C ITGB3 PIK3R1 VCP VIM DDR1 CHD7 SP5 PRKDC ATM MUC4 | 4.42e-04 | 616 | 234 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | TET2 PDE4D IRS1 TTC9C ITGB3 PIK3R1 VCP VIM DDR1 CHD7 SP5 PRKDC ATM MUC4 | 4.42e-04 | 616 | 234 | 14 | C0376358 |
| Disease | programmed cell death protein 5 measurement | 6.16e-04 | 5 | 234 | 2 | EFO_0801927 | |
| Disease | body surface area | ITGB3 ADCY9 PIK3R1 TICRR KERA SIM1 MED13L CPS1 AP3B1 RYBP ADO MTOR CIAO3 MACF1 | 6.72e-04 | 643 | 234 | 14 | EFO_0022196 |
| Disease | mean reticulocyte volume | DLGAP1 GATAD2A TFAP2E RPS6KA1 NEB ADCY9 PIK3R1 TLN2 FLT3 SKP2 RHD TFR2 MTOR SCG3 PDCD5 ATM | 6.95e-04 | 799 | 234 | 16 | EFO_0010701 |
| Disease | body mass index, fasting blood glucose measurement | 7.19e-04 | 51 | 234 | 4 | EFO_0004340, EFO_0004465 | |
| Disease | obsolete Mendelian syndromes with cleft lip/palate | 7.75e-04 | 23 | 234 | 3 | MONDO_0015335 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 7.75e-04 | 23 | 234 | 3 | C0079773 | |
| Disease | glucagon measurement, glucose tolerance test | 9.20e-04 | 6 | 234 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | health study participation | 9.76e-04 | 195 | 234 | 7 | EFO_0010130 | |
| Disease | fasting blood glucose measurement, HOMA-B, fasting blood insulin measurement | 9.95e-04 | 25 | 234 | 3 | EFO_0004465, EFO_0004466, EFO_0004469 | |
| Disease | Adenocarcinoma of large intestine | 1.02e-03 | 96 | 234 | 5 | C1319315 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.21e-03 | 148 | 234 | 6 | C0279702 | |
| Disease | Sezary Syndrome | 1.25e-03 | 27 | 234 | 3 | C0036920 | |
| Disease | Headache, fasting blood glucose measurement | 1.28e-03 | 7 | 234 | 2 | EFO_0004465, HP_0002315 | |
| Disease | lethal congenital contracture syndrome (is_implicated_in) | 1.28e-03 | 7 | 234 | 2 | DOID:0060558 (is_implicated_in) | |
| Disease | N-palmitoylglycine measurement | 1.28e-03 | 7 | 234 | 2 | EFO_0800342 | |
| Disease | Antihypertensive use measurement | 1.32e-03 | 265 | 234 | 8 | EFO_0009927 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.38e-03 | 152 | 234 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | lung small cell carcinoma (is_implicated_in) | 1.39e-03 | 28 | 234 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | Mental Retardation, X-Linked | 1.54e-03 | 29 | 234 | 3 | C1136249 | |
| Disease | Juvenile Myoclonic Epilepsy | 1.70e-03 | 8 | 234 | 2 | C0270853 | |
| Disease | Large cell carcinoma of lung | 2.06e-03 | 32 | 234 | 3 | C0345958 | |
| Disease | Squamous cell carcinoma of lung | 2.06e-03 | 32 | 234 | 3 | C0149782 | |
| Disease | anemia (phenotype), response to ribavirin | 2.17e-03 | 9 | 234 | 2 | EFO_0004272, GO_1901559 | |
| Disease | Liver carcinoma | 2.56e-03 | 507 | 234 | 11 | C2239176 | |
| Disease | obsolete_red blood cell distribution width | GATAD2A LRRC24 ANKRD27 ADCY9 NEK2 PIK3R1 GAL3ST3 MTMR2 HERC1 WNK3 DNM2 VIM FLT3 CPS1 AP3B1 SKP2 RHD TFR2 CDH24 PDCD5 MUC4 | 2.57e-03 | 1347 | 234 | 21 | EFO_0005192 |
| Disease | pit and fissure surface dental caries | 2.67e-03 | 35 | 234 | 3 | EFO_0006338 | |
| Disease | Peripheral T-Cell Lymphoma | 2.70e-03 | 10 | 234 | 2 | C0079774 | |
| Disease | age at menopause | 2.97e-03 | 302 | 234 | 8 | EFO_0004704 | |
| Disease | age at menarche | DNAJB12 TET2 DLGAP1 PDE4D TGFBRAP1 ASCC3 FLT3 SIM1 MADD PPM1F LRRC53 LSP1 | 2.97e-03 | 594 | 234 | 12 | EFO_0004703 |
| Disease | intellectual disability (implicated_via_orthology) | 3.02e-03 | 75 | 234 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | hemoglobin A1 measurement | TET2 PDE3B RPS6KA1 SLC12A8 ANKRD27 NAA25 ADRA2A MAP4K2 MADD PDCD5 MACF1 | 3.10e-03 | 520 | 234 | 11 | EFO_0007629 |
| Disease | Corneal astigmatism | 3.32e-03 | 77 | 234 | 4 | EFO_1002040 | |
| Disease | cardiovascular disease | ADCY9 PIK3R1 MCF2L KPNA4 CACNB4 ARHGEF18 ADO CELSR2 LSP1 PHF13 | 3.73e-03 | 457 | 234 | 10 | EFO_0000319 |
| Disease | pulse pressure measurement | TET2 GATAD2A ZNF385B TLN2 MCF2L MAP4K2 TCEA2 JCAD COL6A3 SHROOM3 ANK2 TRIOBP MED13L MADD PLCD3 CCT6A ADO ZNF827 CTNNA3 LSP1 PHF13 | 3.75e-03 | 1392 | 234 | 21 | EFO_0005763 |
| Disease | hair colour measurement | DNAJB12 PDE4D LYST ITGB3 SNAI3 ANKRD27 PTCHD1 HERC2 SHROOM3 MYH7B RYBP NINL | 3.91e-03 | 615 | 234 | 12 | EFO_0007822 |
| Disease | lip morphology measurement | 4.09e-03 | 189 | 234 | 6 | EFO_0007845 | |
| Disease | Combined immunodeficiency | 4.20e-03 | 41 | 234 | 3 | C0494261 | |
| Disease | autistic disorder (is_implicated_in) | 4.50e-03 | 42 | 234 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | esophageal squamous cell carcinoma | 4.61e-03 | 13 | 234 | 2 | EFO_0005922 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 4.61e-03 | 13 | 234 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease type 4 | 4.61e-03 | 13 | 234 | 2 | cv:C4082197 | |
| Disease | Autism Spectrum Disorders | 4.73e-03 | 85 | 234 | 4 | C1510586 | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 4.81e-03 | 43 | 234 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | Profound Mental Retardation | 5.11e-03 | 139 | 234 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 5.11e-03 | 139 | 234 | 5 | C0025363 | |
| Disease | Mental deficiency | 5.11e-03 | 139 | 234 | 5 | C0917816 | |
| Disease | interleukin 13 measurement | 5.47e-03 | 45 | 234 | 3 | EFO_0008171 | |
| Disease | Alcoholic Intoxication, Chronic | 5.75e-03 | 268 | 234 | 7 | C0001973 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 5.93e-03 | 144 | 234 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | nevus count, cutaneous melanoma | 6.01e-03 | 91 | 234 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | Nephrosis | 6.14e-03 | 15 | 234 | 2 | C0027720 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 6.14e-03 | 15 | 234 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | diffuse idiopathic skeletal hyperostosis | 6.14e-03 | 15 | 234 | 2 | EFO_0007236 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 6.14e-03 | 15 | 234 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | urinary bladder carcinoma | 6.17e-03 | 47 | 234 | 3 | MONDO_0004986 | |
| Disease | osteoarthritis, hip | 6.25e-03 | 92 | 234 | 4 | EFO_1000786 | |
| Disease | obesity (biomarker_via_orthology) | 6.46e-03 | 147 | 234 | 5 | DOID:9970 (biomarker_via_orthology) | |
| Disease | testosterone measurement | TET2 DLGAP1 TFAP2E WDR81 ZNF385B ADCY9 GALNT13 TGFBRAP1 FGD1 MINAR1 ATP8B3 DDR1 SHROOM3 ANK2 CHD7 ZBTB42 RYBP ADO MACF1 | 6.52e-03 | 1275 | 234 | 19 | EFO_0004908 |
| Disease | myopathy (implicated_via_orthology) | 6.55e-03 | 48 | 234 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | albuminuria | 6.74e-03 | 94 | 234 | 4 | EFO_0004285 | |
| Disease | acute myeloid leukemia (is_marker_for) | 6.94e-03 | 49 | 234 | 3 | DOID:9119 (is_marker_for) | |
| Disease | Tremor, Rubral | 6.98e-03 | 16 | 234 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 6.98e-03 | 16 | 234 | 2 | C0750937 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 6.98e-03 | 16 | 234 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Ataxia, Motor | 6.98e-03 | 16 | 234 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 6.98e-03 | 16 | 234 | 2 | C0240991 | |
| Disease | Abnormal coordination | 6.98e-03 | 16 | 234 | 2 | C0520966 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 6.98e-03 | 16 | 234 | 2 | C0334634 | |
| Disease | Ataxia, Truncal | 6.98e-03 | 16 | 234 | 2 | C0427190 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 7.02e-03 | 150 | 234 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | sexual dimorphism measurement | TET2 ACY3 LRRC43 ADCY9 PIK3R1 HERC1 AGAP2 KPNA3 AP3B1 OMG MADD RYBP ADO CIAO3 CEP250 MACF1 CARD11 | 7.38e-03 | 1106 | 234 | 17 | EFO_0021796 |
| Disease | glucagon measurement | 7.82e-03 | 154 | 234 | 5 | EFO_0008463 | |
| Disease | response to radiation, Urinary retention | 7.87e-03 | 17 | 234 | 2 | GO_0009314, HP_0000016 | |
| Disease | Astrocytosis | 7.87e-03 | 17 | 234 | 2 | C3887640 | |
| Disease | serine measurement, amino acid measurement | 7.87e-03 | 17 | 234 | 2 | EFO_0005134, EFO_0009774 | |
| Disease | Gliosis | 7.87e-03 | 17 | 234 | 2 | C0017639 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TLNPKAEVARAQAAL | 6 | P40227 | |
| LSLVRKANARNPLEV | 216 | A8MVM7 | |
| SLRRLAEALPKQSVD | 161 | P20290 | |
| KANPGTLAAEIRALR | 236 | Q96LX7 | |
| ENRLAKSDVPIQLLS | 1206 | Q6ZSZ5 | |
| RDLKPANLLISASGQ | 126 | Q8IZL9 | |
| KNRLEALASPQIVAA | 181 | P83436 | |
| TRARELNQLLGPKAS | 91 | Q96HD9 | |
| RLNPADIKRASQLAS | 601 | Q8TC20 | |
| LRAEDLNIAPRKATL | 61 | Q96SZ5 | |
| SAAIRNDVAKQRAAP | 111 | O14862 | |
| DFSKLQRNILASNPR | 131 | Q9Y294 | |
| NDLRVPFIRDNLLKT | 121 | Q9NZJ6 | |
| ILRPDATKNARNDFL | 656 | Q08345 | |
| SPSDSSQRLLLVLNK | 361 | Q969Y2 | |
| TPRLLTRQDAQSLLA | 316 | Q9UDR5 | |
| LLKPDRNLARALSTD | 796 | Q99490 | |
| RLKNITLDDASAPRL | 756 | O75534 | |
| TLATKANRIPANLLD | 91 | O14490 | |
| NVELSSLARLPSLNK | 51 | Q9BTT0 | |
| VSLRKEPRALAQNVN | 831 | O60423 | |
| ELKLSRALDNNRPLE | 1081 | Q9HCU4 | |
| PTIASLARLCQKLNR | 6 | O43246 | |
| SSKARLRQLPSLVNA | 706 | Q9NVE4 | |
| VGRQSLLAKSPLRQE | 166 | Q99674 | |
| RRDPLANKVALVTAS | 26 | Q9BTZ2 | |
| AKRSVLNNPSKRAII | 266 | O00305 | |
| LSKEDALNLSVPRQR | 2386 | Q9P2D1 | |
| TPLLSDNREKRGLAL | 276 | P32121 | |
| LNLPAGRRKAANVTL | 281 | Q6VUC0 | |
| QRALKDPNQLIRASA | 121 | O00203 | |
| DPNQLIRASALRVLS | 126 | O00203 | |
| IRNTKPLLQSRNAAV | 301 | O00203 | |
| QRGLKDPNQLIRASA | 116 | Q13367 | |
| DPNQLIRASALRVLS | 121 | Q13367 | |
| LRNTKPLLQSRSAAV | 306 | Q13367 | |
| NSPFKRQLSLRLNEL | 316 | Q9Y6R0 | |
| RAKEDQALLSVRPLQ | 381 | Q5T481 | |
| TNRSQEKLSPSLRLL | 226 | P0C860 | |
| QLPRALLTQLLDKAS | 276 | Q12851 | |
| TKLLLDKRANPNARA | 381 | Q01484 | |
| SFNIPRAKRELAQLN | 261 | Q96NW4 | |
| PASRQAAAKLALRKQ | 341 | Q86YP4 | |
| ARSAKIGLASALQPR | 5016 | Q99102 | |
| PDLKALLNVVDNARS | 306 | Q8IV08 | |
| DRTQDFPESNRLKLL | 171 | Q6PIW4 | |
| RPGLTTVLARNLDKN | 251 | Q9NVH1 | |
| AVQAARKLLSSDRNP | 91 | O00505 | |
| SGNRAQKLLRPNSLR | 801 | Q8WXG6 | |
| QKLLRPNSLRLASDS | 806 | Q8WXG6 | |
| STALQRLLAQPNKRF | 666 | Q71F56 | |
| KVFPDLLNRAARTLN | 781 | Q9HCI5 | |
| RPSAAELKLEALTQR | 441 | Q9UGP4 | |
| RKFLSLASNPELLNL | 361 | P51955 | |
| QLLAERSLAPTAAAK | 591 | P19823 | |
| LQEIRESLRNLSKPS | 31 | O95835 | |
| LINLRFLSAARNKLP | 271 | Q96L50 | |
| RVLNLSDNRLKNLPF | 371 | Q96NW7 | |
| LNLASNRSIVPRLAA | 3741 | O95714 | |
| RNTKRAPLLSANNLR | 801 | A6NM62 | |
| LSNKNRGLSAPDLRS | 1036 | Q9P266 | |
| SQKLGLLDRVRLSNP | 421 | O43525 | |
| QVVKLNASDLRLPSR | 4496 | Q15751 | |
| EGILQLRRTNSAKPS | 1146 | Q9BY66 | |
| VLLAQAVDRASNRPL | 116 | Q86UP0 | |
| ARALLNAESLPTQRK | 506 | Q9NVH0 | |
| ADTRQLAAQLRDKFP | 51 | P20809 | |
| SRINQTLDTKLPRQF | 486 | A7E2Y1 | |
| KLTIAQARLGTPADR | 61 | Q9Y5K3 | |
| SARARLSNLALVKPE | 51 | O14737 | |
| LAVALPLQTKADANR | 126 | O43660 | |
| NRVFKLAPNLTELRA | 51 | P51805 | |
| LNLRQVSKTRLSEPG | 946 | Q8NEN9 | |
| ADFLNKPSVILQRSL | 541 | Q13370 | |
| AALTNLQDRAPSKRS | 241 | Q08499 | |
| RARKIPFTENLNLIS | 3416 | Q96JB1 | |
| PLSAKRRALSRSALQ | 456 | Q9P1Y6 | |
| RISLASPRQLFKASN | 2196 | P50851 | |
| SREALQPLASLQVLR | 186 | Q50LG9 | |
| NFSPDLRVLRESNKL | 56 | Q13614 | |
| ESPTAENARLLAQKR | 616 | Q9Y4W2 | |
| KLELALRRQSSSPEQ | 951 | Q8TDZ2 | |
| EARINRATNPLNKEL | 11 | Q9UJY5 | |
| ADKERARNQSIPTLA | 301 | Q6W3E5 | |
| LFRDIQSLPQKAAVR | 281 | Q9H223 | |
| PRLTAAQRIALNSLL | 206 | Q96KJ4 | |
| ALAAELNQLRAKEPT | 96 | P14136 | |
| KASELLLPAAASLRQ | 506 | O94927 | |
| KNLLNARVLSEIFSP | 256 | P27986 | |
| LPRKVDTAAQTNSRL | 841 | P35568 | |
| LNKPLLSGISNAEAR | 616 | P78563 | |
| ESLPALRSKLQSQLL | 291 | P50570 | |
| PRTAFTAEQLQRLKA | 306 | Q05925 | |
| NTVNAALKPLETLSR | 2241 | Q7Z6Z7 | |
| VNLSKLPTRLQRLSC | 36 | Q8NDY4 | |
| KQAGDLRSVIRSPLA | 321 | Q6NXR0 | |
| KVALINSLFNELPSR | 96 | Q8N485 | |
| NSLFNELPSRRITKE | 101 | Q8N485 | |
| PKLRLLDLQANRLSA | 131 | Q9P2V4 | |
| ENQTKLSPRELTALR | 3686 | Q9UPN3 | |
| GPSLRTLSRNLVKNA | 1046 | O95248 | |
| AANDLSPSRIARLQK | 201 | Q96CB9 | |
| AKLAQQVREAAPSAR | 1001 | O00750 | |
| SLLPALRAVISRNQE | 41 | Q8IUC8 | |
| LKNLRPQDSCRVTFL | 4401 | Q5VST9 | |
| SPQTLLELKRQRAAA | 476 | Q96T49 | |
| NAALALAARPKSQAV | 461 | Q9UI47 | |
| RRKPQVLAEASASQA | 436 | P36888 | |
| KLNARAASSRLAAIP | 266 | Q96A11 | |
| QNLLRQADLDKFTPR | 121 | Q9P2D7 | |
| DNLLQLPARRKASDF | 461 | Q96DF8 | |
| LARTFKNTQLPERAI | 2261 | Q13315 | |
| SKADPSILQNLRALV | 376 | Q567U6 | |
| QNPSLSSIRKLIRDG | 1416 | P31327 | |
| DLALARSAKLRNPTN | 1271 | Q9P2D3 | |
| RSAKLRNPTNDLLVL | 1276 | Q9P2D3 | |
| KAVERNRPASNIELL | 1936 | Q9P2D3 | |
| DFRSVRLLKNDPVNL | 6 | Q8TE85 | |
| DNKVLTLASNERIPL | 2221 | Q9UFH2 | |
| NRKDAEARINAQLPL | 151 | Q8WVC6 | |
| EARINAQLPLTDKAR | 156 | Q8WVC6 | |
| PSERALRLVASSKIN | 341 | Q9BPX7 | |
| SRELSTLRNLFKQLP | 321 | P17676 | |
| LKAIQSNQPDRALRF | 16 | Q9NXW2 | |
| RASPQLREAVLKLSD | 2521 | P12111 | |
| EQSLKLDSLEPRLQR | 2136 | Q9BV73 | |
| SKPDLTAALRDIRAQ | 266 | P17661 | |
| STDNLPALLRQDIRK | 121 | A6NGH7 | |
| RRNSKALFSQILLPA | 1451 | Q9BZC7 | |
| SLDQSALLPLRFKNI | 706 | O60503 | |
| LQASLARPEARTLQK | 116 | Q9P203 | |
| PENLRKNLTELLRAA | 346 | Q99698 | |
| AKTRLQLQDAGPART | 116 | Q8N8R3 | |
| QASLKKLAARQTRPV | 551 | O15068 | |
| AGRTPKLARQASIEL | 241 | P33241 | |
| LRLRPDDSKNFSIQV | 116 | P05106 | |
| RFPLKRQVSLESNAS | 416 | P22607 | |
| LNLTRSPDGRIAVKA | 266 | Q5W0V3 | |
| LAQPASARRKLLVFL | 16 | Q6UWR7 | |
| SLGSRENTVRNPALK | 546 | Q8NFF5 | |
| DIQSLPRNAALRKLN | 281 | Q9H4M9 | |
| LQLTRKLESSQPRQG | 466 | A0AV02 | |
| SSPDDLKALTRNVNR | 86 | Q6ZMJ2 | |
| LPQILENLLSARKRA | 656 | P28340 | |
| RRLSKDSNNLDQSLP | 436 | Q9BXL7 | |
| IPVLNAAKRNVLDSS | 361 | Q08AD1 | |
| RNLKETSLQVDNLPR | 881 | Q8WYK1 | |
| AALQSQAEALRRLLP | 166 | Q8WZA9 | |
| ETLDLRRNSLTALPQ | 561 | Q86YC3 | |
| RRNSLTALPQKAVSE | 566 | Q86YC3 | |
| LSANRIKEVDATNLP | 156 | Q8N309 | |
| ATALTLANRNLERLP | 56 | Q8WUT4 | |
| ANAIRRSLEPLLSNS | 1536 | O94851 | |
| QLLQTDLSEFRKLPR | 86 | P49593 | |
| IPRTAQDRLAKLQEA | 686 | Q92833 | |
| KNRAASLDRLQALAP | 186 | Q9UPX6 | |
| NTLLANDPTSLRKNL | 2206 | P42345 | |
| IPAANLSANRKRGAI | 711 | Q9H1H9 | |
| TLQIPASSLDANRKR | 716 | Q9NQT8 | |
| ANRKRGSLLSEPAIQ | 726 | Q9NQT8 | |
| DQPLRAQSKILFVRS | 786 | Q9HCS7 | |
| ALLQTKAPLAATARR | 256 | Q6BEB4 | |
| QASPKVRLSLANEAL | 301 | Q9BX59 | |
| SLAKIERNLVNSLFP | 61 | Q96NR3 | |
| ERNLVNSLFPVNRSK | 66 | Q96NR3 | |
| LLPQERKAAANILRA | 956 | O14827 | |
| LQDALTPQQTLSRRK | 141 | Q9Y2N7 | |
| QLEGRLALPSRVQKS | 551 | Q8IWB4 | |
| PRLKNVDRSTAQQLA | 146 | Q8N488 | |
| RDQSTIPRNLLKTDA | 896 | Q96Q15 | |
| LKESSNLNLPRTFLV | 646 | P98174 | |
| NLNLPRTFLVSGKQR | 651 | P98174 | |
| PRSLEQLQLARNKVS | 141 | O60938 | |
| RLQLRKAPSDQLASI | 581 | P81133 | |
| SLDQKRLCRPQANSL | 406 | Q8TF72 | |
| SVQAEASLPRNLLFK | 76 | O75626 | |
| SAESAALRLRAPLQQ | 161 | P17861 | |
| ANQRDSISKNLPILR | 701 | Q13017 | |
| RALNKLVSRIAPAAL | 1366 | Q9Y2I6 | |
| SRFIRPSDRNQKNSL | 576 | Q9NRY4 | |
| TILRLSQSNQKREPA | 41 | Q9BWV2 | |
| DIQSLPRNAALRKLN | 281 | Q9NZN3 | |
| RTLDISNNRLESLPA | 81 | P23515 | |
| ALAERALQNLAPKET | 1301 | Q7RTU9 | |
| NKRVPLTALLNQSRG | 2041 | Q9H2D6 | |
| RLAPKGNQSRILTQA | 291 | Q9NRP7 | |
| LLDNPRVKAAALASL | 111 | O15269 | |
| RASRAAIVPLKDSLN | 96 | Q3KNW1 | |
| QALQTASLRDGPAKR | 26 | Q9Y615 | |
| QALLKRLPDDRFLNS | 341 | Q9C0B6 | |
| SRALKAPQNLFLVSL | 76 | P08913 | |
| REQALLNARSVPILS | 376 | Q8N3C0 | |
| ARFQLNPTDTARKLT | 126 | Q9H6Q4 | |
| RLLSIKEAFRLAQQP | 6 | Q9BPX3 | |
| VKSQQLSRGADLARP | 256 | Q8IYA6 | |
| LRLSDPIVNTLAKNS | 216 | Q13309 | |
| APVDFLRKQSQLLRS | 1196 | O00562 | |
| QLEGRLALPSRVQKS | 551 | Q5VYP0 | |
| TLLQRAKPSNFLLDR | 96 | Q86YI8 | |
| ELIISNLNPARKRLS | 146 | Q8N184 | |
| KKPVNELRAASALNR | 76 | Q8WUH2 | |
| LDDPNRISLVKRNAV | 226 | Q9ULJ3 | |
| KVRRNLFNQELLSPS | 911 | Q7Z2Z1 | |
| RPQLDRLKTQLSDAI | 336 | Q96NA8 | |
| ALLRSPIERKNAVFN | 226 | Q02161 | |
| DSNRGTKSLRLLNPE | 161 | Q6UVY6 | |
| QLEGRLALPSRVQKS | 551 | Q5TZJ5 | |
| QLEGRLALPSRVQKS | 551 | Q5VU36 | |
| SPRPLQRSASDINLK | 366 | Q9BYB0 | |
| DLSTAILKQKNRPNR | 11 | P55072 | |
| KPQVAEALQRAARIA | 326 | Q9UHP6 | |
| TAAPNLRALENLKTV | 1016 | Q8NDV3 | |
| LSPVEKQLALRNALR | 36 | Q96N76 | |
| AQRRLAKQISPELSA | 516 | Q8N3E9 | |
| IPSAATLINIRNARK | 281 | Q7L523 | |
| KSRNTLAPQRLLFEV | 121 | Q969T3 | |
| KAPLRRAQEVAFQLA | 481 | O43280 | |
| SKPDLTAALRDVRQQ | 261 | P08670 | |
| LLRKAENSRLPSTQA | 891 | Q9HBJ7 | |
| LRQSTIAKRSNAAPL | 141 | Q92576 | |
| ALRVNPALAELNLRS | 51 | P13489 | |
| EQQLVSKRLLRNDAP | 36 | Q96DC7 | |
| LATLRELKLNASLPA | 161 | Q15904 | |
| ADTRRLITKPQNLND | 6 | O60493 | |
| LLAAVNRQPKDANVR | 131 | Q8N5M4 | |
| LQRSPSILAAKLAFQ | 391 | Q569K4 | |
| KLPQISAVLAARSAR | 21 | Q8N755 | |
| DANQLPRALVRKLSS | 1566 | Q4KWH8 | |
| LNSNEARLKFPRLLQ | 3456 | P78527 | |
| QALDLSLKSGPRQER | 186 | B2RXF5 | |
| NKPLSSNLRRLLEAG | 116 | Q17R98 | |
| PNAKNLLAAAARAVT | 1331 | Q9Y4G6 | |
| SRISNLKDAKNPDLR | 191 | Q15560 | |
| DSLQPSIKQRLARLQ | 716 | Q9HBM0 | |
| SIKQRLARLQLSPDF | 721 | Q9HBM0 | |
| RKALSAQQELPSSSR | 446 | Q6UX68 | |
| KKLASLARQTRPQNI | 71 | A6NLI5 | |
| REASPLSSNKLILRD | 456 | Q9Y462 | |
| SQAKQLAELLRLSGP | 1506 | Q6N021 | |
| ILAATQNLKSPTRAA | 176 | Q4V9L6 | |
| AQPISADIASRLLRK | 356 | Q9UP52 | |
| PRTRVAAAITKNNDL | 326 | Q9NZR1 | |
| RQSIRSSPLDNKLNV | 91 | Q8WXD2 | |
| SRRLKQAALQGEATP | 141 | Q8WY91 | |
| PSRLNSRKEAGLLAA | 1331 | Q562E7 | |
| LRKEERASLLSNLGP | 1576 | Q5T200 | |
| PLRKARLQDLTNQTS | 686 | Q5TIE3 | |
| NAQELFLRLRDAPKS | 971 | Q5FWF4 | |
| AALLKPDLVRSLNQD | 691 | Q9BYP7 | |
| AVQAARKLLSSDRNP | 91 | O00629 | |
| SLLRALFKRNPANRL | 291 | Q15418 | |
| AQSLLRALFKRNPCN | 286 | Q15349 | |
| PECNALSRRLLLKNS | 246 | Q14CX7 | |
| FEALKRSTLLNPNQR | 101 | P15173 | |
| VRLSLPRASSLNENV | 91 | Q96SB3 | |
| IPIRAAKAARQAASD | 1071 | P20929 | |
| LRLDAIPIQAAKASR | 3501 | P20929 | |
| VRLDAIPIQAAKASR | 3986 | P20929 |